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Abstracts 
Main Research Project 
 
OBJECTIVE: This study aimed to replicate previous findings regarding the influence 
of recovery style and attachment on engagement and help seeking in first episode 
psychosis (FEP). It also aimed to explore self-compassion and shame as new 
potential moderators of engagement, and in terms of their relationship with 
attachment and recovery style.  
DESIGN: A cross-sectional between groups design was used to compare ‘high’ and 
‘low’ engagers on key variables. Whole sample correlational analysis was also 
undertaken to further explore associations with self-compassion and shame in FEP. 
METHODS: Twenty-two individuals with psychosis under the care of Early 
Intervention (EI) Services completed four questionnaires. Care Coordinators were 
subsequently sent a questionnaire on engagement to complete. RESULTS: No 
significant group differences on the predicted variables were found, with only time in 
service reaching significance. Although non-significant, avoidant attachment did 
result in a small to medium effect size whereby ‘low’ engagers scored higher on 
avoidant attachment, and a trend towards more non-white individuals in the ‘low’ 
engagers group was nearing significance. In the secondary analysis, avoidant 
attachment was associated with shame and problems help seeking, even when 
positive symptoms were controlled for. Anxious attachment was associated with 
lower self-compassion and higher shame. None of the variables were significantly 
correlated with recovery style.  
CONCLUSIONS: The small sample size limits the conclusions which can be made, 
however it is of interest that no significant differences were found between the two 
groups on the expected variables. Although self-compassion and shame did not 
appear to effect engagement in this sample, strong and distinct associations were 
found between these variables and insecure attachment dimensions, indicating a 
possible area for further exploration. 
 
Service Improvement Project 
This paper outlines the development and evaluation of a professionals training day 
focussing on understanding and treatment of Obsessive Compulsive Disorder 
(OCD). The training included talks from experts in OCD, and was organised by 
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OCD-UK (a national service-user led OCD charity) with consultation and input from 
the researcher. The training day was developed in an attempt to target common 
unhelpful therapist beliefs about OCD. An evaluation of the day found that 
attendees’ confidence in understanding and treating OCD increased significantly 
from pre to post training. The training was also found to significantly increase 
attendees’ optimism about the treatment of OCD, and significantly decrease beliefs 
of OCD being a biological (rather than psychological) problem. Implications and 
links to relevant literature are considered.  
Literature Review 
BACKGROUND: Anxiety in Parkinson’s Disease (PD) is highly prevalent yet 
frequently underdiagnosed, undertreated, and historically overshadowed in research 
by a focus on depression. More recently there has been increasing interest in anxiety 
as its significant impact on quality of life in PD is increasingly recognised. However 
anxiety is frequently conceptualised purely as one of many ‘non-motor’ 
manifestations of neurological change, with minimal consideration of potentially 
useful psychosocial factors.  
OBJECTIVE: This review aimed to identify and synthesise the available evidence for 
psychosocial risk factors for anxiety, and to provide an alternative conceptualisation 
through development of a hypothetical cognitive behavioural model of anxiety in PD. 
METHODS: This is a narrative review utilising a systematic search strategy  to 
identify  relevant papers relating to psychosocial factors and anxiety in PD.  
RESULTS: Thirty relevant papers were located and reviewed, and demographic, 
disease/pharmacological and psychosocial risk factors for anxiety in PD were 
identified. A prominent finding was that individuals with motor fluctuation appeared 
to be more vulnerable to anxiety. A hypothetical cognitive behavioural model of 
anxiety in PD is offered.  
CONCLUSIONS: Research focusing on anxiety in PD beyond just the biomedical 
perspective has only recently started to increase, and a number of methodological 
considerations have been highlighted by this review. The current shift in perspective 
on anxiety in PD from one of diagnostic overshadowing to a more psychologically 
informed one, has the potential to address the current problems with under-
recognition and lack of treatment, which would potentially benefit a wide range of 
PD patients. 
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1.1 ABSTRACT 
BACKGROUND: Anxiety in Parkinson’s Disease (PD) is highly prevalent yet 
frequently underdiagnosed, undertreated, and historically overshadowed in research 
by a focus on depression. More recently there has been increasing interest in anxiety 
as its significant impact on quality of life in PD is increasingly recognised. However 
anxiety is frequently conceptualised purely as one of many ‘non-motor’ 
manifestations of neurological change, with minimal consideration of potentially 
useful psychosocial factors.  
OBJECTIVE: This review aimed to identify and synthesise the available evidence 
for psychosocial risk factors for anxiety, and to provide an alternative 
conceptualisation through development of a hypothetical cognitive behavioural 
model of anxiety in PD. METHODS:   This is a narrative review utilising a 
systematic search strategy  to identify relevant papers relating to psychosocial factors 
and anxiety in PD.  
RESULTS: Thirty relevant papers were located and reviewed, and demographic, 
disease/pharmacological and psychosocial risk factors for anxiety in PD were 
identified. A prominent finding was that individuals with motor fluctuation appeared 
to be more vulnerable to anxiety. A hypothetical cognitive behavioural model of 
anxiety in PD is offered.  
CONCLUSIONS: Research focusing on anxiety in PD beyond just the biomedical 
perspective has only recently started to increase, and a number of methodological 
considerations have been highlighted by this review. The current shift in perspective 
on anxiety in PD from one of diagnostic overshadowing to a more psychologically 
informed one, has the potential to address the current problems with under-
recognition and lack of treatment, which would potentially benefit a wide range of 
PD patients. 
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1.3 INTRODUCTION 
Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disease 
affecting approximately 127,000 people in the United Kingdom (Parkinson’s UK, 
2013). Clinical diagnosis is a complex and often lengthy process frequently over 
more than a year. Diagnosis is based on evidence of: the physical effects of PD (e.g. 
tremor, rigidity, akinesia/bradykinesia and postural disturbance); ruling out of other 
possible conditions; and monitoring for the effect of medications and of disease 
progression. Brain imaging is also sometimes utilised. The majority of those 
diagnosed with PD are 50 and over, however PD can also affect people at a younger 
age. When diagnosis occurs prior to age 50 this is generally labelled ‘early onset’ PD 
(Parkinson’s UK, 2013). The exact symptoms and the speed at which the condition 
deteriorates can be unpredictable and varies from one person to the next. 
Progressive loss of dopaminergic neurons in the substantia nigra due to build up of 
Lewy bodies have long been linked to physical impairments in PD, and treatment 
involves administration of dopaminergic medications (most commonly L-Dopa). 
Maintaining optimal levels of L-Dopa medication is often complex however, and as 
the disease progresses individuals frequently experience increasing fluctuation in 
their physical symptoms as dopamine levels rise and fall when medication is 
‘wearing on’ and ‘wearing off’. Excess dopamine due to medication can also lead to 
disruptive uncontrolled movement (dyskinesia).  
As diagnosing and treating PD as early as possible slows the disease progression 
more effectively, there is increasing interest in identifying early warning signs or 
‘prodromal’ PD symptoms. A large prospective study (Schrag et. al, 2014) found that 
a range of symptoms of; tremor, balance impairments, constipation, hypotension, 
erectile dysfunction, urinary dysfunction, dizziness, fatigue, depression, and anxiety 
may signify prodromal symptoms. Further research is required however due to a lack 
of accuracy in PD diagnosis in this sample. It will also be important to explore 
whether depression and anxiety in prodromal stages are in fact a reaction to 
experiencing a range of worrying and troublesome symptoms, or are symptoms of 
neurological changes themselves.  
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Although the physical effects of PD are considered the core of the disease, there is an 
on-going shift from viewing PD as a "single chemical neurodegenerative disease" 
(Goetz, 2010, p.S105), to a neuropsychiatric disorder with motor symptoms; 
acknowledging a wider focus that includes a variety of common and often disabling 
‘non-motor’ symptoms. These can include problems such as fatigue, apathy, pain, 
cognitive change or sleep disturbance, but psychological difficulties are now 
recognised as one of the most commonly reported non-motor symptoms of PD 
(Gallagher, Lees, & Schrag, 2010). Despite this, problems like anxiety or depression 
have historically been subjected to diagnostic overshadowing by the more physically 
apparent motor symptoms, and rarely identified as a potential target of psychological 
treatment. There is a growing acknowledgement however of the extensive impact of 
such potentially treatable difficulties on the everyday functioning of patients with 
PD. Paradoxically, it increasingly appears that it is the non-motor symptoms of PD 
that most influence the perceived quality of life of people living with this disorder 
(Barone et al., 2009; Quelhas & Costa, 2009). 
 
Prevalence of anxiety in PD 
Although there is a clear consensus that psychological difficulties are frequent and 
significant in PD, challenges remain regarding obtaining accurate prevalence rates. 
In their review of psychosis, apathy, depression and anxiety in PD, Gallagher and 
Schrag (2012) highlight the complexity of establishing accurate prevalence rates for 
mood problems and anxiety in PD, and this concern is repeated in much of the 
available research. Complicating factors are listed as: overlap with disease 
symptoms; possible qualitative differences in psychological disorders in this 
population; comorbid cognitive problems; medication side effects; the presence of 
motor and non-motor fluctuations; and the different diagnostic frameworks available 
(Gallagher & Schrag, 2012).  
 
One review suggests a range of estimates for diagnostic anxiety disorders in PD of 
between 20-49% across studies (Gallagher & Schrag, 2012). Meanwhile ‘clinically 
significant’ anxiety has been identified in 40% to 60% of individuals with PD 
(Starkstein, Robinson, Leiguardia & Preziosi, 1993; Richard, Schiffer & Kurlan, 
1996; Pachana et. al., 2013). In a review of non-motor fluctuations in PD, Bayulkem 
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& Lopez (2010) report that the “most common type of mood fluctuation is off period 
anxiety” (p.90), which is anxiety that occurs as medication wears off and motor 
symptoms increase; they state that up to 75% of patients may report this type of 
anxiety. A large scale Italian study found anxiety to be second only to fatigue out of 
the most commonly reported non-motor symptoms with 56% of the sample reporting 
anxiety difficulties (Barone et. al., 2011). A high prevalence of panic disorder (Stein 
et al., 1990; Goetz, 2010), generalised anxiety disorder (GAD) and social phobia 
(Gallagher & Schrag, 2012; Pachana et al., 2013; Stein et al., 1990, Bolluk, 2010) 
has been identified.  
 
Despite methodological challenges, there is growing and consistent evidence of a 
high prevalence rate of anxiety in patients with PD, including when compared with 
both age-matched non clinical controls (40% anxiety rate versus 15% in controls; 
Chaudhuri, et al., 2006) and to individuals with other chronic health conditions (38% 
versus 11%; Pincus & Tucker, 2002). Considering these high rates, it is perhaps 
surprising that anxiety remains often under-recognised and untreated within PD.   
 
Comorbidity with depression & anxiety subtypes 
Depression is also common in PD, although prevalence estimates have varied widely 
from 2.7-90% across studies (Gallagher & Schtag, 2012). A large systematic review 
of depression in PD found an overall prevalence rate for major depression to be 17% 
(Reijinders et al., 2008), compared to 13.5% of the general population in later life 
(Beekman, Copeland & Prince, 1999).  The broader category of ‘clinically 
significant depressive symptoms’ in PD was estimated at 35% (Reijinders, et al., 
2008). Until more recently, depression has frequently overshadowed anxiety within 
PD literature. This may be because theories of depression linked to the dopaminergic 
systems have been more forthcoming. Goetz (2010), admits that there has been an 
'assumption' that anxiety in PD relates to "the same neurochemical systems 
implicated for depression" despite the fact that these systems are not the same as 
those targeted by anxiolytic medications (Goetz, 2010, p.S105).  
 
Although there is significant evidence that anxiety and depression in PD often do 
occur together (Gallagher & Schrag, 2012; Pachana et al., 2013; Goetz, 2010; 
Bayulkem & Lopez, 2010, Armento et. al., 2012) there is growing evidence that they 
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should not be viewed as one entity, or assumed to solely be manifestations of the 
same neurological change. A recent large-scale study with a sample of 513 PD 
patients identified four anxiety or depression subtypes using Latent Class Analysis. 
These included an ‘anxiety alone’ subtype (22.0%), an ‘anxiety co-existing with 
prominent depressive symptoms’ subtype (8.6%), a third subtype (8.9%) of 
depressive symptoms without significant anxiety, and a final subtype (60.4%) with 
no prominent affective symptoms (Brown et al, 2011).  Indeed Brown et al. (2011) 
went even further to hypothesise that the phenotypic similarities found in patients in 
their ‘anxiety alone’ and ‘anxiety co-existing with depressive symptoms’ subtypes 
suggest there may be a progression from persistent GAD-like anxiety symptoms 
leading to a deterioration in mood and development of anxiety with depression over 
time- although they admit further longitudinal research is required to test out such an 
association (Brown et al., 2011). Such findings support the need for further study of 
anxiety as a primary symptom within the context of PD, contrary to the historical 
focus of literature on depression in PD. 
 
 
Biomedical understanding of anxiety in PD 
As with depression, anxiety in PD has historically been viewed as a symptom of 
underlying neurological changes associated with Parkinson’s disease (e.g. Menza et 
al., 1993), and biomedical explanations have predominated. Evidence is limited and 
conflicting regarding the relationship of anxiety with the dopaminergic system, with 
most research pointing more strongly to links with depression, psychosis and drug 
abuse (see Millan, 2003 for comprehensive review). However, research has begun to 
identify possible neurological changes in a number of other areas in PD more 
commonly associated with mood and anxiety. This includes neurological pathways to 
the amygdala and wider limbic system, which have been implicated in a range of 
anxiety disorders (Etkin & Wager, 2007) as well as being central to posture and 
balance (Balaban & Thayer, 2001).  
 
Relatively few neuroimaging studies aimed at anxiety in PD have been completed 
(Aminian & Strafella, 2013), and the available research has varied in its findings. 
Unsurprisingly the neurological impact of PD is highly complex, however the 
implication is that neurodegeneration of other transmitter systems in the cortex and 
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brainstem (e.g. cholinergic, adrenergic and serotonergic neurons) may represent an 
underlying cause of a variety of non-motor symptoms including anxiety (Bassetti, 
2011; Prediger, 2012; Walsh & Bennett, 2001). Despite increased interest in possible 
neurological explanations of anxiety in PD however, the picture remains complex 
and poorly understood, (Bassetti, 2011; Millan, 2003). It is also increasingly 
acknowledged that psychosocial factors are also highly relevant (Bassetti, 2011) and 
perhaps especially within certain groups, such as young-onset PD (Aminian & 
Strafella, 2013).  
 
 Anxiety as a psychological response to PD  
PD is a progressive and deteriorating disease, however there is uncertainty and 
unpredictability about the speed of disease progression, and living with PD often 
involves considerable day- to-day variability and uncertainty. A significant 
proportion of individuals experience fluctuation in their motor symptoms as a result 
of dopamine medication ‘wearing off’ or ‘on’ over time. ‘Wearing off’ symptoms 
can involve slowing of movement, or incidents of motor block/freezing of gait 
(FOG) which can be sudden, unpredictable and frightening. If dopamine levels get 
too high in ‘on’ periods however, this causes excessive and uncontrolled movements 
(dyskinesia). Patients also often have symptoms such as tremor or gait problems, 
which may have social implications and can be misunderstood as evidence of 
alcoholism or drunkenness.  
 
Anxiety is increasingly reported as one of the most common, if not the most 
common, non-motor symptom in PD (e.g. Pachana et al., 2013; Witjas et al., 2002; 
Barone et al, 2009), the presence of which correlates with degree of reported 
disability (Witjas, 2002; Quinn, 1998). Anxiety has also been found to reduce self-
rated quality of life in individuals with PD (Barone et al, 2009; Dissanayaka et al, 
2010; Martinez-Martin et al., 2011), and represents an additional significant burden 
and barrier to those already imposed by the disease (Quelhas & Costa, 2009). Yet the 
historical assumption that anxiety problems in PD are solely a symptom of 
underlying neurological changes associated with the disease (e.g. Menza et al., 
1993), has had important implications for both patients and clinicians. Individuals 
with PD often fail to receive psychological intervention for anxiety despite the fact 
that a meta-analysis of randomised controlled trials found no significant effect of 
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pharmacological treatment on either anxiety or depression in PD (Troeung, Egan & 
Gasson, 2013), whilst Cognitive Behavioural Therapy has been identified as a 
potentially effective psychological approach (see Yang et. al., 2012; Armento et al., 
2012 for reviews of psychosocial/CBT treatment for anxiety and depression in PD). 
Anxiety in PD remains frequently under-diagnosed (Dissanayaka et. al., 2014) and 
under-treated (Pachana et. al., 2013).  
 
The psychosocial risk factors for anxiety in PD may also represent a promising target 
for psychological intervention considering the lack of evidence for any 
pharmacological treatment of anxiety in PD, and the risks of side effects from 
polypharmacy considering the numerous medications PD patients are frequently 
prescribed (Prediger, 2012; Walsh & Bennett, 2001). Various models of anxiety, 
such as a number of cognitive-behavioural models, have developed as useful 
theoretical explanations of anxiety with strong evidence bases. These models have 
also started to be applied to the experience of anxiety within chronic illnesses (e.g. 
Kehler & Hadjistavropoulos, 2008), and in other neurological diseases such as MS, 
the role of psychological factors in adjustment and coping are increasingly explored 
and understood (Dennison, Moss-Morris & Chalder, 2009).  In comparison to MS, 
psychological perspectives of anxiety in PD which contrast the biomedical viewpoint 
lag behind, and very little attempt has been made to apply psychological models of 
anxiety in the context of PD specifically.  
With increasing interest in anxiety in PD, and in identifying the factors that may 
impact on an individual’s vulnerability to anxiety, this review will attempt to 
synthesise the available evidence and offer a theoretical model of anxiety in PD 
which draws on existing research and evidence based anxiety models. It is hoped that 
this review and model will identify: 
a) Risk factors/potential moderators of anxiety in PD (either disease factors e.g. 
motor fluctuation, or psychosocial factors e.g. illness beliefs or social 
support) 
b) The potential interaction between motor symptoms and anxiety in PD  
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1.4 METHOD 
This review is narrative in nature, however a systematic search strategy was utilised 
and incorporated advice from consultation with a specialist librarian. The databases 
of PsychINFO and PUBMED were searched by the first author. Due to the limited 
research on anxiety in Parkinson’s, broad search criteria were adopted to obtain as 
many relevant papers as possible. MeSH terms of ‘Parkinson’s Disease’ and 
‘Anxiety’ were therefore used in order to remain broad but also to ensure that anxiety 
was a major and substantial topic. No limits were set except that an inclusion criteria 
of ‘human population’ was applied. See Appendix for mapping of search process. 
A total of 185 papers were identified. A title/abstract search of these papers was 
conducted and a number of papers were excluded due to: 
1) Duplication in both searches  
2) Not a journal article  
3) Not English language  
4) Single case study  
5) Not directly relevant (e.g. only looked at depression or other non-motor 
symptom e.g. sensory changes). 
The remaining 104 papers about anxiety in PD were then reviewed in more detail. 
Papers conceptualising anxiety in PD purely from a biological or pharmacological 
perspective were excluded. Papers focussed solely on treatment of anxiety (either 
pharmacological or psychological) were also excluded due to the existence of other 
available reviews of treatment approaches (e.g. Armento et. al., 2012). The 
remaining papers were included if they explored risk factors for anxiety in PD (e.g. 
disease related or psychosocial) or the interplay between motor symptoms and 
anxiety. 
In total, 30 papers were included. The 30 identified papers were critically reviewed 
regarding methodological variations (e.g. design, sample size, control group etc) and 
relevance to the review aims of identifying possible factors influencing anxiety in 
PD, and the interaction between motor symptoms and anxiety in PD. This analysis 
identified three main areas of focus in the current research; motor 
   18 
 
symptoms/fluctuations (and their interplay with anxiety), cognitive factors (such as 
metacognitions or illness beliefs), and disease severity. A fourth category of 
demographic factors were also identified and deemed relevant to include due to the 
recognition that PD patients are not a highly homogenous group, and that different 
factors may have more or less influence on anxiety across demographic groups e.g. at 
different ages.  
1.5 RESULTS 
1.5.1 Demographic factors 
PD is considered ‘Young-onset’ when it occurs prior to age 40. A number of studies 
have identified that younger individuals (Dissanayaka, 2010; Pontone, 2011; 
Stefanova et al., 2013) and younger women with PD are more likely to experience 
anxiety (Nègre-Pagès et al., 2010; Pontone, 2011; Stefanova, 2013). Younger PD 
patients may also experience more social anxiety (Bolluk, 2010). Experiencing a 
degenerative disease earlier in life may increase risk of anxiety due to the possibility 
that illness may be more ‘socially acceptable’ or comprehensible at an older age, 
when society tends to expect health to decline. One study found gender, disease 
duration & severity, and social support explained 31% of variance in anxiety in 
younger PD patients but not in older patients (Ghorbani Saeedian et al., 2014).  
Results suggesting a link between younger age of PD onset and anxiety fit with the 
findings of other reviews into PD (e.g. Bayluken & Lopez, 2010). Lifetime 
prevalence rates of anxiety disorders in the general population have been found to be 
higher in women (30%) than men (19%), so these findings may simply reflect this 
wider tendency (Kessler et. al., 1994), or may reflect increased caring 
responsibilities. One study using retrospective chart analysis identified ethnicity as 
being associated with anxiety (Rana et. al., 2012), but this was not replicated in any 
of the other studies included here. 
1.5.2 Severity 
A number of studies identified severity of PD as an important factor associated with 
anxiety levels (e.g. Dissanayaka, 2010; Ghorbani Saeedian et al., 2014; Manor et al., 
2009; Pontone, 2011; Quelhas & Costa, 2009; Simpson et al., 2013; Stefanova et al., 
2013). This is unsurprising considering the increasing burden and restriction likely 
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imposed by the disease as it progresses, as well as further development of 
neurological degeneration and associated complications e.g. fatigue. Motor 
fluctuation also tends to increase with severity of illness, as the effectiveness of 
dopaminergic medications reduce, leading to longer and more pronounced ‘off’ 
periods and less well controlled motor symptoms. Crucially however to support the 
role of psychosocial factors, severity by no means explains all variation in anxiety, 
and some studies with large sample sizes have found no significant relationship with 
anxiety (e.g. Brown & Fernie, 2015). 
1.5.3 Disease & Pharmacological Motor Symptoms 
On/Off Period Fluctuation 
Richards et al. (2004) report that 24% of their PD sample experienced motor 
fluctuation, and that 75% of those with fluctuations also reported experiencing mood 
and/or anxiety fluctuation. Although Richards’ research involved only a small 
sample, a considerable range of studies have also found increased anxiety levels in 
those experiencing motor fluctuations. Although cross sectional, Dissanayaka et al.'s 
2010 telephone interview study was thorough and in depth, including checking for 
psychiatric history and controlling for a variety of factors (e.g. psychiatric history, 
family psychiatric history). They also utilised a structured diagnostic measure 
(MINI) as well as a more specific anxiety rating scale (STAI). 
Stefanova’s large study of 360 consecutive outpatients with PD found high rates of 
anxiety without depression (37%), and that patients with severe, unpredictable 
wearing on/off fluctuations had significantly higher anxiety scores (Stefanova et al., 
2013). Another large scale study found those who experience motor fluctuations 
were more likely to meet the criteria for GAD than those without fluctuation 
(Leentjes et al., 2012). Higher unpredictability and severity of fluctuation may 
increase anxiety and susceptibility to problems such as GAD. One study comparing 
anxiety levels in on versus off period found higher overall anxiety during off period, 
and in particular changes in ratings of ‘tranquillity perception’ and ‘concern with the 
future’ from the State Anxiety Inventory (Caillava-Santos, Margis & Mello Rieder, 
2015), suggesting a shift in cognitions and a possible increase in worry. Although 
this study involved a small sample and no control group, they also found a reduction 
in performance on some cognitive assessments during off phase (Caillava-Santos et. 
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al, 2015).Cognitive functioning in PD has been associated with anxiety but not 
depression, and it is theorised that increased anxiety may lead to higher cortisol 
levels which then impact on cognitive ability (Ryder et. al., 2010). Another small 
study but with a control group found that while mild depression was consistent 
across groups, those that experienced motor fluctuations had significantly higher 
anxiety levels than those without (Erdal, 2001). A stronger relationship may 
therefore exist between motor fluctuation and anxiety in particular, as compared to 
depression. The consistency of this pattern of increased anxiety in those with motor 
fluctuation  make this a prominent finding (Erdal, 2001; Dissanayaka et al., 2010; 
Leentjes et. al., 2012; Stefanova et al., 2013). 
Whether the relationship between motor symptoms and anxiety is a straightforward 
temporal one remains unclear (e.g. mood changes fluctuate as motor symptoms do). 
Richards (2001) utilised a diary method to monitor motor and emotional fluctuation 
in a small sample size of 16. Motor and mood symptoms were not consistently 
correlated, but where they did, this almost always involved a reduction in mood, 
increase in anxiety and simultaneous decrease in motor function. Replication with a 
larger sample of 87 PD patients and 19 spouse controls (Richard et al., 2004), found 
similar results whereby those experiencing fluctuations were more likely to 
experience psychological problems and anxiety, but that a simple temporal 
relationship was not always present (Richards et al, 2004; Leentjens et al., 2012). 
Both studies utilised unvalidated visual analogue scales, and relied on participants’ 
consistent use of diaries. 
Conversely, other studies-again with small sample sizes- have found evidence of a 
more direct relationship, with improvement in psychological measures and anxiety 
over time from ‘off’ to ‘on’ period (Siemens et. al, 1993, Menza, 1990), correlation 
of anxiety with a symptom diary (Siemens, 1993), and with onset of dyskinesia 
(Menza, 1990). There may be a number of reasons for inconsistent findings. These 
include methodological challenges whereby both motor symptoms and anxiety have 
been measured with diaries and subjective rating scales, relying on the accuracy and 
frequency of self-reports, and replication with larger samples is required. 
Dyskinesia 
Another motor symptom linked to PD treatment is dyskinesia (excess and 
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uncontrolled movement) occurring during ‘on’ periods.  Research so far into 
dyskinesia and anxiety is limited, but it has been associated with anxiety (e.g. 
Dissanayaka et al., 2010; Menza, 1990). One study (Leentjens et al., 2012) looking at 
temporal links between motor symptoms and mood identified a minority of patients 
who reported anxiety exclusively during episodes of ‘on’ stage dyskinesia. Another 
study which compared anxiety during on/off phases found lower variation in anxiety 
scores between on and off periods for those patients with dyskinesia, possibly 
because dyskinesia is likely to occur in ‘on’ periods so that less relief is provided by 
the transition from off to on phase (Caillava-Santos et. al., 2015). 
Bradykinesia, Akinesia 
Bradykinesia is a cardinal symptom of PD and involves slowing of movement, whilst 
Akinesia is the absence of movement (‘freezing’). These symptoms can affect the 
ability of patients to vary facial expressions or make spontaneous gestures and hand 
movements when talking, which can affect social interaction. In a study of social 
anxiety, PD patients were found to be significantly more anxious and depressed, and 
more likely to experience social anxiety than healthy controls. Social anxiety was 
also associated with severity of symptoms and with Bradykinesia (Bolluk, 2010).  
Lauterbach, Freeman and Vogel (2003) compared anxiety in a small sample of PD 
patients and individuals with another movement disorder (Dystonia), and identified 
panic as particularly common in PD. They found a positive relationship between 
panic disorder/secondary panic attacks and freezing of gait (FOG) frequency in PD 
when controlling for individuals’ life prevalence of GAD and Panic. Another, larger 
study (Lieberman, 2006) found that those with FOG (compared to PD patients 
without FOG) were more disabled, with more severe "wearing off", dyskinesia and 
postural instability. They were also more anxious as a group and more likely to 
experience panic in particular.  
Such consistent findings are encouraging, however the cross sectional designs restrict 
conclusions regarding causation and exact mechanisms. There is supportive 
emerging evidence however of the impact of anxiety on frequency of FOG. A small 
but creative experimental study (Ehgoetz Martens et. al, 2014) utilising virtual reality 
goggles assessed FOG during ‘low anxiety’ (walking a plank at floor level) and ‘high 
anxiety’ (walking a plank at apparent height). Individuals with PD who experience 
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FOG were found to freeze more frequently and for longer during the high anxiety 
condition compared to low anxiety, and more than those who do not typically 
experience FOG. The impact of anxiety on FOG was most pronounced during ‘off’ 
phase, indicating a potentially critical period during which motor symptoms and 
anxiety are more likely, and whereby increased anxiety may exacerbate already 
problematic symptoms.  
A similar study (Pasman et. al., 2011) with the same size sample found increased 
anxiety, fear, lower balance confidence and poorer perceived stability in the ‘anxiety’ 
condition. Anxiety and fear also significantly correlated with changes in actual 
postural control. In this case PD patients were not affected more than controls; this 
may be due to the PD patients only being tested during their ‘on’ phase, and the 
exclusion of PD patients taking anxiety medication (and therefore perhaps being a 
low anxiety group). Exploring FOG and festination (quickening and shortening of 
gait), Starkstein et al. (2015) found that stress and distress associated with these 
symptoms appeared to increase the severity of the gait problems and was associated 
with higher frequency of reported falls. Surprisingly however, and conversely with 
results described previously, no significant correlations were found between these 
motor symptoms and any psychiatric disorders as measured by the Mini International 
Neuropsychiatric Interview (MINI).  The authors suggest their results may be due to 
their use of a stringent diagnostic-based instrument (MINI), however studies have 
found an association between motor fluctuations and anxiety disorders when using 
the same or similar diagnostic measures (e.g. Dissanayaka, Lauterbach et. al. 2006; 
Pontone et. al. 2011). Despite some variation in findings, such studies suggest the 
possibility of a complex interplay existing between motor symptoms and 
psychological factors, and the potential for significant vicious cycles to develop over 
time as anxiety deteriorates functioning and perceived confidence.  
1.5.4 Cognitive Factors 
There is emerging evidence that cognitive and metacognitive variables may be 
important moderating factors of anxiety in PD. Some research has focussed on the 
high prevalence rates of worry and GAD in PD samples (Gallagher & Schrag, 2012; 
Pachana et al., 2013; Stein et al., 1990). One study investigating metacognitive 
beliefs about worry in PD found that beliefs focusing on the uncontrollability and 
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danger of worry were associated with elevated levels of distress (Allott et al., 2005). 
Although involving a small sample size which limited the analysis possible, the 
results are supported by a larger study (Brown & Fernie, 2014) in which anxiety 
correlated significantly with: impact on activities of daily living, intolerance of 
uncertainty, positive beliefs about worry, negative metacognitions about thought 
uncontrollability and danger, and lack of cognitive confidence. The strongest 
relationships were with intolerance of uncertainty and beliefs about uncontrollability 
and danger, with a regression model of these factors predicting 56% of variance in 
anxiety.  
A further regression analysis including only the data from the 93 individuals 
reporting motor fluctuation, surprisingly found no association between the reported 
predictability of ‘off’ periods and psychological distress but again found that 
negative metacognitive beliefs about thoughts being uncontrollable and dangerous 
were associated with higher levels of off period distress, even when motor symptoms 
and intolerance of uncertainty were controlled for (Brown & Fernie, 2014). Off 
period ‘distress’ in this research was measured by an un-validated five-point likert 
scale, which asked patients to rate ‘distress during off periods’ more generally rather 
than anxiety. Use of a validated and reliable measure of anxiety related specifically 
to motor fluctuation and off periods would be beneficial in future research. Brown 
and Fernie (2014) also acknowledge that the measure of metacognitive style focussed 
on worry rather than beliefs regarding illness or symptoms. The results regarding 
metacognitions are strengthened however by their consistency with evidence 
regarding similar beliefs (e.g. Wells, 2000) and intolerance of uncertainty (Carleton 
et. al., 2012) in anxiety disorders generally.  
The only qualitative study reported here (Wright et al, 2015) utilised the 
Catastrophising Interview to compare worry content in high and low worriers with 
and without PD. The number of worry topics was not significantly different between 
PD and non-PD samples. In terms of content however, while health worries were 
found to distinguish between high and low worriers within the non-PD group, both 
high and low worry PD groups reported health worries. An exploration of 
catastrophic worries however identified that high worriers with PD were more likely 
to have concerns about relationships, negative self-perception, and death or severe 
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incapacity. There was also more significant differences in the content of catastrophic 
worries between the high and low worriers in the PD group than non PD group 
(Wright et al, 2015). As a qualitative study involving a small sample size, such 
results cannot be generalised and require replication. They are useful however in this 
early stage of research in order to highlight potential areas for future exploration- 
such as the role of catastrophic thoughts in anxiety in PD, and the possibly 
ubiquitous nature of health concerns in this group.  
Illness representations are also an area of growing interest within PD literature but 
again there has been limited research so far. One study utilising a prospective design 
explored illness representations in relation to anxiety and depression in PD (Evans & 
Norman, 2009). Anxiety was found to correlate significantly with beliefs from the 
Revised Illness Perception Questionnaire regarding: a higher number of symptoms 
attributed to PD; a cyclical timeline (of disease); more perceived negative 
consequences of PD, and higher perceived impact of PD on emotions. Two coping 
styles of avoidance and resignation were also significantly correlated with anxiety (as 
measured by the Medical Coping Modes Questionnaire). A regression model of the 
correlated illness beliefs explained 42% of variance in concurrent anxiety, and the 
addition of coping via avoidance and resignation significantly increased the 
proportion of variance explained. At 6 month follow up, initial anxiety and belief in 
personal control (negative relationship) were found to be significant predictors of 
anxiety (Evans & Norman, 2009). Although involving a relatively small sample this 
study controlled for a wide variety of other correlates and is rare in including a 
prospective element. A later study with a larger sample of 81 (Simpson et al, 2013) 
also explored illness beliefs and identified belief in a psychosocial cause of PD (e.g. 
caused by stress, conflict etc) as an independent predictor of anxiety in PD, along 
with poor social support and PD severity.  
An area linked to illness beliefs is the concept of Sense of Coherence (SOC) which 
explores a person’s typical viewpoint on the comprehensibility, manageability (e.g. 
belief in control and problem solving), and meaningfulness of life events and 
challenges, and is thought to impact on coping skills in ill health. One study (Gison 
et. al., 2014) has explored SOC in a PD sample (50) and healthy controls (55), and 
found a significant negative correlation between SOC and emotional distress as 
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measured by the Health Anxiety and Depression Scale (HADS total). Interestingly, 
the anxiety subscale had the strongest negative correlation with SOC. Anxiety and 
Depression were also negatively correlated with quality of life (as measured by the 
WHO-5 Well-being Index) more powerfully than SOC itself. Diagnosis of the PD 
participants was confirmed through medical interview and MRI scan. Information on 
severity and duration of illness was also obtained and individuals with cognitive 
impairment and high medical comorbidity were excluded. No data on lifetime 
prevalence of anxiety or depression was obtained, and unfortunately anxiety was not 
included separately in the final regression analysis performed. A one point increase 
in SOC was found to predict a 3% decrease in distress (total HADS including anxiety 
score) and increase QoL by 2%. 
1.5.5 Social Support 
Social support has been identified as a potential factor influencing anxiety in PD 
(Ghorbani Saeedian et al., 2014). Simpson et al., (2006) found that positive affect in 
PD was associated with social factors of more children, employment, and close 
relationships. Greater reported problems in social support were associated with 
higher levels of depression, anxiety and stress. As described above, Simpson et al. 
(2013) also found dissatisfaction with social support, a higher belief in psychosocial 
cause and a higher severity score to predict anxiety. 
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M., Montastruc, J. 
L., Fourrier, A., 
Lépine, J. P., & 
Rascol, O. (2010).  







Age, Gender. “Anxiety and depressive symptoms were more frequent in 
PD patients than in medical control group”.  “Patients with anxious 
symptoms were more frequently female and younger than those without 
such symptoms.” 
Cross sectional, very 
large sample. Controls 
with other disorders. 
 
Bolluk, B., Ozel-
Kizil, E. T., 
Akbostanci, M. C., 











Social Anxiety and Age: Social anxiety, Anxiety and Depression 
significantly more common in PD group compared to healthy controls. 
Social anxiety correlated with depression and age- younger patients more 
likely to be socially anxious. 
Cross sectional but 
large sample and age & 
gender matched 
controls.  
Rana, A. Q., Athar, 
A., Owlia, A., 
Siddiqui, I., Awan, 
N., Fattah, A., & 
Rana, M. A. (2012).  













Method Key Findings Strengths/ 
Limitations 
Quelhas, R., & 
Costa, M. (2009).  
HADS n=43 No Cross-
sectional 
“HADs and Short Form-36 Health Survey scores significantly correlated 
with H&Y stage 2 Parkinson's disease (severity measure), anxiety strong 
correlation with physical score. Multivariate analysis found anxiety was 
the strongest predictor of QoL.” 
Cross sectional, fairly 
small sample 
 
Shulman, L. M., 
Taback, R. L., 
BAI n=99 No Cross 
sectional 
“Only 12% of the sample had no non-motor symptoms. Fifty-nine 
percent two or more non-motor symptoms, and nearly 25% had four or 
Cross sectional 
 
   27 
 
Bean, J., & Weiner, 
W. J. (2001).  
more. Increased comorbidity was associated with greater PD severity (P 
< 001).” 
Manor, Y., Balas, 
M., Giladi, N., 
Mootanah, R., & 
Cohen, J. T. (2009).  
Spielberger 
manual for the 
trait anxiety 








Patients with Swallow Disorders experienced increased anxiety and 
depression compared to patients without SDs. “In addition, the most 
anxious patients had significantly increased disease severity and 
decreased MMSE scores compared with the least anxious patients.” 
Cross sectional, self 
report, controls 
(without swallow 
problem). Focus on 
swallow disorders.  
The following papers listed in another main category also add evidence for severity of illness: 
Ghorbani Saeedian, R., Nagyova, I., Krokavcova, M., Skorvanek, M., Rosenberger, J., Gdovinova, Z., … van Dijk, J. P. (2014).  
Dissanayaka, N. N. W., Sellbach, A., Matheson, S., O’Sullivan, J. D., Silburn, P. A., Byrne, G. J., … Mellick, G. D. (2010).  
Stefanova, E., Ziropadja, L., Petrović, M., Stojković, T., & Kostić, V. (2013).  







Method Key Findings Strengths/ 
Limitations 
Richard, I. H., 
Frank, S., 
McDermott, M. P., 
Wang, H., Justus, 
A. W., LaDonna, K. 
A., & Kurlan, R. 
(2004).  
Questionnaires








“Twenty-nine percent of patients had fluctuations in anxiety, 24% motor, 
and 21% mood; 65% had no fluctuations. Seventy-five percent of 
patients with motor fluctuations had mood and/or anxiety fluctuations, 
but 5 subjects reported emotional fluctuations without motor 
fluctuations. Visual inspection of diaries revealed that not all patients 
exhibited a temporal relationship between emotional and motor 
fluctuations.” 
Control group small 
and spouses, cross 






Stojković, T., & 













A total of 136 (37.8%) patients with PD manifested only anxiety, 
whereas 20 patients (5.6%) had both depression and anxiety. All other 
patients (56.7%) had scores below cut-off either on HARS or HDRS. 
“Anxiety might be present as an isolated symptom.....and not only as a 
feature of depression in PD population.” The best predictors for anxiety 
were motor disability, core depression variable, and female gender. 
Patients with severe, unpredictable on/off fluctuations had higher HARS 
scores  
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Richard, I. H., 
Justus, A. W., & 
Kurlan, R. (2001).  
Hourly diaries 








“Motor and emotional states were not consistently correlated. When they 
were correlated, the most frequent pattern was the common occurrence 
of decreased mood, increased anxiety, and reduced motor function.” 
Self report diaries- 
reliant on accuracy of 
diaries, small sample 
size, cross sectional 
Caillava-Santos, F., 
Margis, R., & de 
Mello Rieder, C. R. 
(2015).  
STAI-State n=24 No cross-
sectional 
Anxiety and depression higher in 'wearing off' stage. In particular, 
increase in STAI items ‘tranquillity perception’ and ‘concern with 
future’ from on to off period. 
Cross sectional, small 
sample no controls 
 
Dissanayaka, N. N. 
W., Sellbach, A., 
Matheson, S., 
O’Sullivan, J. D., 
Silburn, P. A., 
Byrne, G. J., … 




















25% current Anxiety disorder (10% Depression). Severity of PD 
symptoms, on/off fluctuations and dyskinesias were associated with 
anxiety. Anxiety disorders contributed to a poor quality of life. Younger 
patients were significantly more likely to experience anxiety disorder. 
Collected LOTS of info 
to control and test for- 
detailed & thorough 
including psychiatric 
history. Australian 
sample however, cross 
sectional. Self-report.  











PD with on-off group = significantly higher anxiety levels than PD 
without. Both groups were mildly depressed.  
Small sample, cross 
sectional. Self-report. 
But comparison group 
 
Lauterbach, E. C., 
Freeman, A., & 
Vogel, R. L. 
(2003).  









GAD more common “after dystonia onset (i.e., secondary generalized 
anxiety) while panic attacks developed more commonly after Parkinson 
disease onset.” “Exploratory analysis in Parkinson disease indicated a 
relationship of panic disorder and secondary panic attacks to motor block 
frequency.” 
Smallish sample, Cross 
sectional, self-report 
but did have controls 
(dystonia) 




P., Richard, I. H., & 


















“Patients with motor fluctuations suffer from generalized anxiety 
disorder more often than patients without motor fluctuations. When 
patients with motor fluctuations have anxiety symptoms, the majority 
report that these have no temporal relationship with specific motor states. 
When there was a relationship, symptoms were almost always related to 
'off' periods. However, a minority of patients experience anxiety 
symptoms during 'on' or "on with dyskinesia" periods exclusively.” 
Big sample. Cross 
sectional, self-report, 
PD controls without 
fluctuation. 
 












“Patients with FOG were more disabled, had more "wearing off", 
dyskinesia, leg dystonia, and postural instability. They were also more 
anxious and more likely to panic. FOG, in many patients, is increased by 
anxiety and panic.” 
Q big sample.  Cross 
sectional, self-report, 
not matched controls 
Ehgoetz Martens, 
K. A., Ellard, C. G., 











Virtual reality walking plank either low or high anxiety. “Freezers 
reported higher levels of anxiety compared to Non-Freezers and all 
patients reported greater levels of anxiety when walking across the 
HIGH plank compared to the LOW. Freezers experienced significantly 
more freezing of gait episodes and spent a significantly greater 
percentage of each trial frozen when crossing the HIGH plank. This 
finding was even more pronounced when comparing Freezers in their 
OFF state. Freezers also had greater step length variability in the HIGH 
compared to the LOW condition, while the step length variability in 
Non-Freezers did not change.” 
Experimental- creative 
method (virtual reality) 
control group 
comparison. But small 
sample, specific around 
freezing of gait. 
 
Pasman, E. P., 
Murnaghan, C. D., 
Bloem, B. R., & 
Carpenter, M. G. 
(2011).  
Anxiety and 














3 PD, 7 
controls, 
mean age 















“Manipulations of apparent surface height were accompanied by 
significant changes in self-reported ratings of state anxiety, fear, balance 
confidence and perceived stability in both PD patients and controls.” 
“Changes in state anxiety and fear were found to be significantly 
correlated with changes in postural control across groups” 
PD patients only tested 
during 'ON' phase 
where anxiety may be 
less. Also any PD 
patients taking anxiety 
medication excluded- 
so may have been an 
unusually low anxious 
PD group. 
Menza, M. A., 
Sage, J., Marshall, 








n=10 No Cross 
sectional 
“Significant changes in mood and anxiety were found to parallel changes 
in motor fluctuations. One patient rated his moods as consistently 
improving from the "off" state to the "on" state and finally to the "on 
with dyskinesia" state, a finding that is consistent with concomitant 
central dopaminergic changes. All other patients showed moods that 
improved significantly from the "off" state to the "on" state but then 
worsened significantly in the "on with dyskinesia" state, a finding that is 
consistent with the fact that patients feel worse when impaired by 
dyskinesias.” 
Cross sectional, small 
sample, self-report, 
non-validated analogue 
scales - in moment 
mood ratings 
 
Siemers, E. R., 
Shekhar, A., Quaid, 
Spielberger 
anxiety state 
n=19 No Cross 
sectional
“Spielberger anxiety state scores were higher during off periods than  on 
periods....magnitude of  change in anxiety correlated with the change in 
Cross sectional, small 
sample, no controls, 
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[PD Symptom Diary] scores.” “Anxiety trait scores also correlated with 
disease duration”. Results “support existing data suggesting anxiety can 
contribute to morbidity in Parkinson's disease and.......that anxiety varies 
with fluctuations in motor performance.” 
tested during on and off 





Wilson, M., Bruno, 




n=95 No Cross 
sectional 
“A linear regression analysis showed that both motor blocks and 
festination were significantly associated with emotional distress and 
deficits on activities of daily living. Conversely, there was no significant 
association between motor blocks or festination and generalized anxiety 
disorder, panic disorder, agoraphobia, social phobia, or depression. 
Motor blocks and festination are significantly associated with emotional 
distress, but no significant associations were found with anxiety or 
affective disorders.” 
Gender bias in sample- 
more men but did not 
report whether any 
effect of gender found. 
Also used HAI but 
only on 62 of 95 
participants. 
Pontone, G. M., 
Williams, J. R., 
Anderson, K. E., 
Chase, G., 
Goldstein, S. R., 
Grill, S., … Marsh, 















“Anxiety disorder in 42%, Non-DSM specific anxiety 22%. Thirty 
subjects (12%) had multiple anxiety diagnoses. Co-morbidity with 
depression was high; (55% of anxiety disorders comorbid). Fluctuation 
associated anxiety linked to several anxiety disorder diagnoses, also 
more common in females, younger onset, longer disease duration, higher 
l-dopa dose, more complications of therapy. Only fluctuation-associated 
anxiety was independently associated with HS in the final multivariate 
model which accounted for 48% of the variance.” 
No control group, large 
sample, cross sectional 
 
The following papers listed in another main category also add evidence for severity of illness: 







Method Key Findings Strengths/ 
Limitations 
Brown, R. G., & 



















“Anxiety was not significantly associated with motor symptom severity 
or cognitive functioning, while metacognitive factors were significantly 
related to anxiety when controlling for motor experiences of daily living 
and intolerance of uncertainty. For participants with motor fluctuations, 
no association was found between predictability of, and distress 
associated with, off-periods. Metacognitions of uncontrollability and 
danger significantly related to off-period distress when controlling for 
Cross sectional, self-
report, metacognivie 
measure designed for 
worry not use with 
health population. 
Possible change in 
severity from 




motor experiences, intolerance of uncertainty, and other metacognitive 
factors.” 
assessment to data 
collection. 
Wright, A., Hurt, C. 
S., Gorniak, S., & 



























“High worriers showed a greater diversity of worry topics” (both 
groups). “Health worries differentiated high/low worriers” but only in 
control group- health worries across PD groups. CI: “PD high worriers 
more likely to have concerns about negative self-perception and 
death/severe incapacity.” 
Sample size limited 
analysis btw groups, 
control group 
participants may have 














More dissatisfaction with social support, a higher belief in psychosocial 




Allott, R., Wells, 
A., Morrison, A. P., 







Maladaptive metacognitive style associated with heightened distress in 
Parkinson’s disease: “stronger negative beliefs about worry, focusing on 
its uncontrollability and danger....more likely to report elevated levels of 
distress”.  
male bias, SS drawn 
from study of 
halucinations 
Gison, A., Rizza, 
F., Bonassi, S., 
Dall’Armi, V., Lisi, 












“A statistically significant positive correlation was found between SOC 
and Qol and a negative significant correlation between SOC and 
emotional distress. The multivariate regression analysis confirmed the 
negative effect of SOC on total emotional distress and positive effect on 
Qol.” 
q big sample and 
control group of 
healthy matched Ss. 
Cross sectional, SOC 
effect on 'distress' self-
report. 
Evans, D., & 










The illness representations measures (i.e. identity, cyclical timeline, 
consequences, emotional representations and psychological attributions), 
identity and avoidance explained majority of anxiety variance. “..final 
regression equation explained 56% of the variance in time 2 anxiety, 
with time 1 anxiety and personal control (negative relationship) 
emerging as significant independent predictors.” 
Small-ish sample, self-
report, cross sectional, 
no controls but 6 
month follow up 
(prospective). 
The following papers listed in another main category also add evidence for cognitive factors: 
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Pontone, G. M., Williams, J. R., Anderson, K. E., Chase, G., Goldstein, S. R., Grill, S., … Marsh, L. (2011). Anxiety and self-perceived health status in Parkinson’s disease. 







Method Key Findings Strengths/ 
Limitations 
Ghorbani Saeedian, 




Gdovinova, Z., … 









“Gender, disease duration & severity, and social support explained 31% 
of variance in anxiety in younger PD patients but did not contribute to 
depression explanation.” In older group “model explained 41% of 
variance in depression [but not anxiety]”. In younger group disease 
duration plays primary role in anx, in older group poor social support 
assoc with depression. 















“Positive affect is associated with more children, current employment 
and a greater number of close relationships. On the other hand, higher 
levels of depression, anxiety and stress were only significantly associated 
with greater reported problems in social support.” 
Cross sectional, small 
sample, self-report 
 
The following papers listed in another main category also add evidence for social support: 
Simpson, J., Lekwuwa, G., & Crawford, T. (2013).  
*For clarity, summaries are largely in the original authors own words; however where direct quotes are not indicated summaries are in this 
authors words. 
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1.6       DISCUSSION 
 
Anxiety in PD has only recently been seen as an important topic in its own right. 
There is no doubt however that anxiety and anxiety disorders are highly prevalent in 
those living with PD (Gallagher & Schrag, 2012). In fact, the evidence suggests that 
large numbers of people with PD develop anxiety without depression (Brown et al, 
2011), and there are some hints that anxiety may precede later mixed anxiety and 
depression (Brown et al, 2011), although further research is required. Although some 
consider anxiety to be a purely biological manifestation of neurological change, the 
evidence for this is so far weak (Bassetti, 2011; Millan, 2003). This review has 
explored instead a range of disease, pharmacological and psychosocial risk factors in 
the development of anxiety in PD, and the potential complex interplay between 
anxiety and motor symptoms.  
 
Although neurological changes are commonly theorised to increase vulnerability to 
anxiety in PD, the effect of living with PD from day to day would also appear to be 
fertile ground for a range of anxiety disorders to develop. It would seem probable 
that anxiety in PD may develop through several possible routes; one route may be as 
a direct result of neurological changes (for example that may be theorised to increase 
an individual’s sensitivity to anxiety or impact on their ability to self-regulate); 
another may be as a direct result of the stress and uncertainty involved in living with 
PD from day to day  (such as anxiety and panic about getting ‘stuck’ and the 
personal meaning of symptoms); finally for another group there may be a 
combination or interaction of both neurological vulnerability and psychosocial 
factors.  
One of the most prominent findings of this review was that those who experience 
motor fluctuation, a symptom of pharmacological treatment, appear significantly 
more vulnerable to anxiety and anxiety disorders (e.g. Richards et al., 2004; Erdal, 
2001; Dissanayaka et al., 2010; Stefanova et al., 2013), highlighting the importance 
of good medical management to reduce on/off fluctuation and dyskinesia as much as 
possible. Further research is needed to explore whether different cognitions or beliefs 
about PD (that could feed into anxiety) are held in those who experience on/off 
fluctuations. However most models of anxiety identify beliefs about a perceived 
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threat as being central; Brown & Fernie’s (2015) research on metacognitions in PD 
generally found that intolerance of uncertainty and more catastrophic worries were 
present in the more anxious PD group, whilst Stefanova (2013) found that more 
unpredictable and severe on/off fluctuations led to higher levels of anxiety. Ratings 
of ‘perceived tranquility’ and ‘concern for the future’ have also been found to change 
significantly along with overall anxiety level between on and off periods (Caillava-
Santos et. al., 2015), and provide evidence for a potential shift in cognitions and an 
increase in threat based interpretations triggered by off symptoms. 
The results suggested that anxiety (particularly during off periods) has a negative 
feedback effect on symptoms, increasing severity and frequency of FOG and falls 
(Lieberman, 2006; Ehgoetz-Martens et. al., 2014; Pasman et. al., 2011). The 
mechanisms for this have yet to be confirmed (e.g. are anxious PD patients using 
maladaptive behaviours to try and avoid/control symptoms that non anxious patients 
do not) however the findings are commensurate with a cognitive behavioural 
perspective on anxiety, where increased arousal leads to further symptoms and 
‘safety behaviours’ (such as tensing up or consciously focussing on an action) which 
can unintentionally increase the risk of the feared event taking place (e.g. increasing 
freezing/falls). A classic example being the cognitive behavioural panic cycle, 
(Clark, 1986) whereby anxiety symptoms trigger a catastrophic interpretation (e.g. a 
heart attack), that results in safety behaviours (e.g. hyperventilating, lying down) that 
often worsen panic but also reinforce the belief in such symptoms as dangerous and 
threatening.  
It is of interest therefore that symptoms of motor block in PD are associated with 
panic attacks in particular. Unfortunately no research so far has explored the 
cognitions experienced by individuals who have panic attacks during motor block, 
however apparently higher rates of catastrophic worries about death and incapacity in 
individuals with PD and high anxiety (Wright et. al., 2015) may reflect an increased 
susceptibility to develop panic-type catastrophic interpretations of their symptoms. 
Evidence of increased social anxiety in younger PD patients and those with more 
severe symptoms and bradykinesia (Bolluk, 2010) also requires further exploration; 
theoretically this may represent an increased sense of threat or fear of 
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misunderstanding in younger patients, but again no measures of beliefs or cognitions 
were utilised. 
A range of psychosocial factors with the potential to be important in moderating 
anxiety in PD were identified. Unsurprisingly, this included levels of (and 
satisfaction with) social support (Simpson, Lekwuwa & Crawford, 2013; Simpson et. 
al, 2006), a finding supported by research into other health conditions (e.g. MS; 
Costa, Sa & Calheiros, 2012, Diabetes; Strom et. al., 2012). Certain metacognitive 
beliefs about the danger and uncontrollability of thoughts and worries appear 
important to anxiety in PD (Allott et al, 2005; Brown & Fernie, 2015) as they are 
more generally in anxiety (e.g. Wells, 2000) and in one study such metacognitive 
beliefs predicted off period distress (Brown & Fernie, 2015). Wider views about the 
predictability, manageability and meaning of life events (sense of coherence) have 
also been found to predict anxiety in PD (Gison et. al., 2014). There is some 
evidence of a high frequency of health worries within PD (Wright et. al., 2015) 
which warrants further investigation, especially since health anxiety has been found 
to be common in other conditions with fluctuating and unpredictable symptoms. In a 
diabetes sample, those with high health anxiety tended to be younger, female, or 
recently diagnosed, and anxiety was associated with poorer adherence and self-care, 
and lower quality of life (Claude, Hadjistavropoulos & Friesen, 2014). In MS, health 
anxiety has been associated with less adaptive coping styles, increased disability and 
GAD (Kehler & Hadjistavropoulos, 2008), as well as lower quality of life and 
increased misinterpretation of sensations as MS symptoms (Hayter et. al., 2016). 
Illness related beliefs have been extensively studied in other chronic health 
conditions (e.g. Sharloo & Kapstein, 1997) and are just starting to be explored in this 
context. Illness representations involving a psychosocial cause (Simpson et al 2013), 
low personal control and serious negative future consequence (Evans & Norman, 
2009) have been linked to higher anxiety levels in PD, as have maladaptive coping 
strategies of avoidance and resignation (Evans & Norman, 2009). Such findings are 
again comparable to wider cognitive behavioural anxiety literature and theory, where 
both meaning/appraisal and safety behaviours (such as avoidance) are at the core of 
many evidence based anxiety models (e.g. panic (Clark, 1986); health anxiety 
(Salkovskis, Warwick & Deal, 2003)). Early evidence of the possible role of 
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intolerance of uncertainty, catastrophic worries, and concern for the future (Brown & 
Fernie, 2015; Wright et. al., 2015) also fit with the cognitive behavioural GAD 
model which highlights intolerance of uncertainty as a key underlying factor in the 
development of chronic worry (Dugas et. al., 1998).  
Over the longer term, avoidance strategies such as those found by Evans & Norman 
(2009) are conceptualised to strengthen anxiety related beliefs, but also to erode an 
individual’s confidence and quality of life over time, and diminish their sense of self 
control; in other words the solution becomes the problem. As would be predicted, 
individuals with PD and high anxiety have been found to report lower levels of 
activities of daily living (ADLs) (e.g. Dissanayaka, 2010, Bolluk, 2010), and lower 
quality of life (e.g. Quelhas et. al., 2009), however due to the cross sectional nature 
of current research, the direction of this relationship is not yet confirmed. 
1.6.1 A cognitive behavioural model of anxiety in PD 
Below (Fig.1.1) is presented a hypothetical model of anxiety in PD, which attempts 
to synthesise the main review findings, as well as propose some mechanisms through 
which anxiety in PD may develop and be maintained. The top section of the model 
provides a visual summary of the factors that may increase an individuals’ 
vulnerability to anxiety, incorporating demographic, disease, and psychosocial 
factors. The lower part of the model is based on Clark’s Panic model (Clark, 1986) 
and attempts to apply cognitive behavioural theory to anxiety in PD, focussing on the 
role of appraisal/cognition and maladaptive coping/safety seeking behaviour. The 
model is illustrated with two examples based on clinical experiences: (1) off period 
anxiety/panic regarding fear of freezing and getting ‘stuck’ in a public toilet, and (2) 
anxiety regarding the experience of tremor in a social situation (a meal out). A great 
proportion of individuals with PD will experience symptoms such as motor block 
and tremor, however how they conceptualise and respond to the symptoms will vary 
considerably. It is likely that it is the attributions a person gives to those symptoms 
which determines the level of anxiety experienced and coping responses utilised. 
The hypothetical model offered here highlights the development of negative beliefs 
and appraisals of situations or triggers as threatening and uncontrollable (e.g. ‘I 
won’t be able to control my tremor and will drop/spill my food’) leading to high 
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levels of anxiety, which in turn increase both PD symptom (e.g. tremor) and anxiety 
symptom severity and encourage even more catastrophic interpretations (’They think 
I’m a drunk and a fool’), leading to maladaptive coping through avoidance, 
withdrawal or safety seeking behaviours (e.g. gripping utensils and focusing all 
attention on trying to suppress tremor). This combination of anxiety, increased 
symptoms and avoidance may then feedback into a strengthening belief in PD 
symptoms as threatening and uncontrollable, risking resignation, reduction in wider 
quality of life, and withdrawal from valued activities. If such a progression is 
accurate, then this may also support the concept of depression in PD emerging over 
time and preceded by anxiety symptoms (Brown et. al, 2011) 
Such a cycle could help conceptualise the development of a range of anxiety 
disorders in PD such as panic, social anxiety and health anxiety. The hypothetical 
model described here is perhaps more suited to conditions where the interaction with 
physical symptoms is more pronounced ‘in the moment’. It may therefore be less 
effective at conceptualising GAD in PD. Despite this, the vulnerability factors 
identified remain relevant, and considering the links between motor fluctuation and 
increased risk of GAD, off period symptoms may still trigger catastrophic thoughts 
about the future e.g. of death and incapacity, which then feed into safety behaviours 
such as the perceived need to worry more about the future to avoid or prepare for 
feared outcomes (offering a conceptualisation of off period worry with similarities to 

















































Fig. 1.1: Hypothetical Cognitive Behavioural Model of Anxiety in PD 
 









 Motor symptoms 
 Severity 
 On/Off fluctuation 
 Early disease onset 
Psychosocial vulnerability 
 Illness beliefs/appraisals 
 Avoidance 
 Intolerance of uncertainty 
 Metacognitive style 
 Lack of social support  
 Low sense of coherence 
 
Trigger Situation 
e.g. Use of public toilet in community 
e.g. Eating a meal in restaurant 
ANXIETY due to  
PERCEIVED THREAT 
(High uncertainty/threat, low control) 
e.g. ‘What if my medication wears off and I get 
stuck?’ 
e.g. ‘I will shake and drop/spill my food’ 
Increase in symptoms 
e.g. Increased risk of motor 
block, panic symptoms 
e.g. Increased severity of 
tremor 
Catastrophic Interpretation 
e.g. ‘I’ll be stuck for hours-No one will find 
me!’ 
e.g. ‘Everyone is noticing- they all think I am 
drunk/weird’ 
Avoidance/Safety Behaviour 
e.g. Avoid public toilet- go home 
e.g. Make excuses not to eat, focus all 
of attention on trying to control tremor 
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1.6.2    Limitations 
Research focusing on anxiety in PD beyond just the biomedical perspective has only 
recently started to increase, and a number of methodological considerations have been 
highlighted by this review. These include the predominance of cross-sectional designs, 
wide variation in sample sizes, and a lack of validated PD-specific anxiety measures. 
Such limitations within the wider literature also restrict the strength of conclusions that 
can be drawn from this review, due to a lack of randomised controlled studies, and the 
wide variety of anxiety measures utilised making direct comparisons difficult. Future 
longitudinal research with specifically designed and validated anxiety measures (for 
example that incorporate variation in on/off phases) is required. Although effort was 
made to conduct the search in a systematic way, one of the aims of this narrative review 
was to generate a rationale for a psychological framework for anxiety in PD, and an 
element of reviewer bias is therefore possible. Although developed from currently 
available research and based on well-evidenced cognitive behavioural models (e.g. 
Clark, 1986), many aspects of the model of anxiety in PD presented here would benefit 
from a great deal more research.  
1.6.3 Future Directions & Conclusions 
Potential areas for future research include  further exploration of the appraisal and 
meaning of motor symptoms for individuals, and behavioural reactions to symptoms 
(such as avoidance and safety behaviours) which likely feed back into anxiety and 
significantly reduce the quality of life of individuals living with PD. Another area of 
potential interest could be exploring not just risk factors but also potential protective 
factors that may reduce the psychological impact of PD. 
PD is a progressive condition which, along with its treatment, incorporates certainty 
about degeneration combined with significant variability of day to day functioning and 
uncertainty about the speed of deterioration. Examination of the available evidence has 
highlighted the significant psychological burden of both PD and its medical treatment. 
A number of possible demographic, disease/pharmacological and psychosocial factors 
are identified that may increase the risk of anxiety in PD, and a cognitive behavioural 
model of the complex interplay of anxiety with motor symptoms is offered. It is hoped 
this conceptualisation will encourage further application of psychological theory to 
40 
 
anxiety in PD, and in turn support the utilisation of well-grounded psychological 
treatments, adapted as required to incorporate the individual challenges and 
complications of PD. Although further research is required, CBT has been identified as 
a potentially effective psychological approach to anxiety and depression in PD in the 
few randomised controlled trials that have so far been completed, and compares 
favourably to evidence for pharmacological interventions (Yang et. al., 2012; Armento 
et al., 2012). If the perspective on anxiety in PD were to shift from one of diagnostic 
overshadowing to a more psychologically informed one, it is likely that the current 
problems with under-recognition (Dissanayaka et. al., 2014) and lack of treatment 
(Pachana et. al., 2013) would improve and potentially benefit a wide range of PD 
patients. 
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This paper outlines the development and evaluation of a professionals training day 
focussing on understanding and treatment of Obsessive Compulsive Disorder (OCD). 
The training included talks from experts in OCD, and was organised by OCD-UK (a 
national service-user led OCD charity) with consultation and input from the researcher . 
The training day was developed in an attempt to target common unhelpful therapist 
beliefs about OCD. An evaluation of the day found that attendees’ confidence in 
understanding and treating OCD increased significantly from pre to post training. The 
training was also found to significantly increase attendees’ optimism about the 
treatment of OCD, and significantly decrease beliefs of OCD being a biological (rather 



























OCD-UK is a national charity which prides itself on being run by people with 
experience of Obsessive-Compulsive Disorder (OCD), for people with experience of 
OCD. OCD-UK envisions a time and place where “everyone affected by OCD should 
receive the most appropriate and the highest quality standards of care, support and 
treatment” (OCD-UK Website, Retrieved from: http://ocduk.org/about-ocduk, 
05/01/2015).  
 
Historically the OCD-UK Annual Conference has been designed primarily for people 
with experience of OCD and provides information and support, as well as an 
opportunity to voice concerns and experiences. OCD-UK members have frequently 
reported negative experiences of treatment to the organisation in support groups and 
online forums (A. Fulwood, Personal communication, 8/05/2014), some of which have 
also been highlighted by the limited empirical research in this area. Complaints included 
therapists taking intrusive thoughts as indicators of actual risk to others (e.g. Glazier et 
al., 2013; Veale et al., 2009); minimising the challenges associated with dropping OCD 
rituals, or appearing pessimistic about their chances of recovery (Stobie, 2009). 
OCD-UK therefore planned an additional day for professionals at their 2014 
Conference, with the aim of sharing new advances in the understanding and treatment of 
OCD, combating unhelpful beliefs about OCD, and emphasising evidence based 
treatment supported by decades of quality research.  OCD-UK’s stance as a strong 
advocate for individuals with personal experience of OCD, puts it in a unique position 
to educate and promote best practice whilst retaining a focus on personal stories about 
OCD and its impact on people’s lives. We were asked to support OCD-UK in this 
endeavour through consultation on the content of the day, and through evaluation of the 
impact of the training on a group of mental health professionals in attendance. 
 
People with OCD often experience a long delay from symptom onset to effective 
treatment due to professional misidentification (Glazier et al, 2013) or reluctance to 
disclose symptoms (Torres et al, 2000). People experiencing OCD are often burdened 
by feelings of shame, embarrassment, and sadly justified fears of aggressive/sexual 
obsessional thoughts being taken at face value (Glazier et al, 2013; Veale et al., 2009). 
The recommendations of the National Institute for Health and Clinical Excellence 
(NICE) for OCD even refer to intrusive thoughts of harm to others frequently being 
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“misinterpreted as risk” (National Collaborating Centre for Mental Health, 2005: p. 15). 
It is therefore vital that people with OCD who ask for treatment are seen by someone 
with appropriate training, who understands the condition well, and does not confirm 
their fears about how they will be perceived.  
A 2013 audit suggested that the majority of people experiencing OCD are offered 
treatment in line with NICE guidance (National Audit, 2013). However the same audit 
also showed high rates of drop out of people with OCD from treatment, and a 
significant ‘treatment gap’ remains in the UK between the true prevalence of OCD and 
the proportion of individuals in treatment (Kohn et al, 2004).  
 
A previous study of mental health professionals’ beliefs found that OCD was rated as 
the most ‘difficult-to-treat’ anxiety disorder, the problem most likely to relapse, and the 
least successful in their experience of treatment (Stobie, 2009). Empirical evidence 
contradicts these perceptions however with a review of treatment trials showing CBT to 
be more effective for OCD than for many other anxiety disorders (Hofmann & Smits, 
2008). Even the authors of the above review reported surprise, stating that the results 
“counter the general notion that OCD is the most treatment-resistant anxiety disorder” 
(Hofmann & Smits, 2008, p.629). 
  
CBT and Exposure and Response Prevention (ERP) for OCD have the potential to be 
highly effective. However negative ‘general notions’ and unhelpful beliefs as described 
above may lead to therapists lacking in confidence/optimism, and lead to poor 
adherence to evidence based treatment (Shafran et. al., 2009), risking ‘therapist drift’ 
and impacting on treatment outcomes (Waller, 2009).  
Social psychology research has shown that negative group beliefs toward a health 
problem can reinforce a “collective stigma that affects whether and how individuals 
seek care and how communities.......prioritize and deliver care to persons with this 
condition” (Mendel, Meredith, Schoenbaum, Sherbourne, & Wells, 2008, p.27). 
Evidence however suggests that targeted training of professionals can improve 
outcomes and that even short training interventions can shift beliefs and expectations 






2.3 RESEARCH QUESTIONS 
2.3.1 Consultation 
 What aspects of OCD treatment are not well understood by professionals (from the 
perspective of OCD-UK members and of professionals)?  
 How could the professionals’ day be used to address this? 
2.3.1 Evaluating the conference 
 Have attendees increased their confidence in understanding OCD and how to treat 
it?  
 Do attending professionals show a shift in beliefs about OCD and its treatment from 
pre to post conference day? 
 How successful/useful was the day generally, and what changes or improvements do 




Consultation on the proposed content of the Professionals Conference day was 
undertaken with members of OCD-UK, people with personal experience of OCD and 
mental health professionals. Regular one to one and small group meetings with 
members of OCD-UK (in person and via Skype) were used to discuss proposed topics, 
share relevant feedback and maintain regular contact.  
 
As the OCD-UK members’ forum represented an important ‘safe place’ for people with 
personal experience of OCD, it was agreed that it would be inappropriate for the 
researchers to join and post messages. However, a member of OCD-UK who was 
closely involved in the project and in the development of the conference, and who was 
also a known moderator of the forum posted a forum topic. This requested feedback 
from OCD-UK members on what they felt was most important for therapists to know 
about OCD or what they wished their therapist had known. It was made clear to OCD-
UK forum users that any comments would be anonymised completely and sent to the 
researcher to be summarised and used to develop the OCD-UK professionals’ day. 
 
Mental health professionals were approached by the researcher by emailing previous 
attendees of an OCD-UK event for therapists, and also posting in online forums for 
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trainee psychologists and IAPT workers. Professionals were asked the following 
questions:  
 What would you want to see at an OCD-UK health care professionals’ 
conference day? E.g. content of talks, workshops, topics etc.  
 From your experience, are there any aspects of the nature or treatment of OCD 
that you feel are less well understood by yourself or other health care 
professionals?  
 What do you think would be the possible benefits of OCD-UK running a 
conference day for healthcare professionals? 
Feedback was again anonymised, summarised and sent to OCD-UK to inform and help 
shape the content and format of the conference day.  
 
2.4.2 Conference Day 
Participants 
Participants were recruited from attendees of the OCD-UK Professionals Day 
Conference in Nottingham. Fifty-two people attended the conference, and thirty-five 
agreed to take part in the study.  
 
Measures 
Conference Day Evaluation Questionnaires  
Pre and Post evaluation questionnaires were designed through a process of consultation 
with key members of OCD-UK involved in the planning of the conference. 
The priority for OCD-UK was to: 
 Measure the overall impact and success of the new conference day 
 Gather feedback from attending professionals on the content/topics offered 
 Assess whether the day positively influenced professional’s confidence in 
understanding and treating OCD. 
 
In order to meet these goals, a range of general feedback questions and specific ratings 
were included. Once draft pre and post questionnaires were developed, these were sent 
to OCD-UK for feedback. Some changes were made on the request of OCD-UK, 
including a question about how welcomed the attendees felt, and how they had heard 




The questionnaires were then finalised and distributed to attendees as part of their 
welcome pack on arrival at the Conference. Attendees were asked to read the 
information sheet and sign the consent form if they were happy to take part (see 
Appendix ). Participants were prompted by the OCD-UK speakers to complete their pre 
questionnaire at the start of the day and prompted again to complete their post 
questionnaire at the end of the day.  
 
Pre Questionnaire  
The Pre- Questionnaire consisted of an initial question asking participants to select their 
role from a list of options e.g. CBT therapist, counsellor, etc. This was followed by a 
question asking them to use a Likert scale to rate their previous experience of working 
with individuals with OCD (from very experienced (4), quite, not very and not at all 
experienced (1)). Five further questions used a similar Likert scale (very (4), quite, not 
very, not at all (1)) to rate how confident they currently felt about: 
1. Working clinically with someone experiencing OCD. 
2. What the evidence-based treatments for OCD are. 
3. Assessing risk in OCD e.g. thoughts of harming others. 
4. Having some insight into what it feels like to experience OCD. 
5. Involving family/carers in the treatment of OCD. 
These were followed by a YES/NO question about whether they had any personal 
experience of OCD, and two open ended questions asking how they heard about the 
conference, and what their expectations for the day were. 
See Appendix I for full copies of the pre and post questionnaires.  
 
Therapy Beliefs Questionnaire 
OCD-UK were also keen to adopt a more in depth method for evaluating the day’s 
impact on professionals. For this reason the ‘Therapist OCD Therapy Relevant Beliefs 
Scale’, (Stobie, 2009) was included as a part of both the pre and post questionnaires. 
This questionnaire assesses professionals’ beliefs about OCD and its treatment. The 
Therapist OCD Therapy Relevant Beliefs Scale (TRBS) consists of 21 items and has 
been found to include six factors; Optimism; OCD as a Biological problem; Poor patient 
progress due to past life problems; OCD as a difficult problem with insufficient therapy; 





The post questionnaire included Likert style questions asking attendees to rate the 
conference day content (Very Good (4), Quite Good, Not Very Good, Not at all Good 
(1)) on:  
1. Interest of topics    
2. Relevance to your role/work      
3. Helpful for developing therapeutic skills     
4. Positive impact on your feelings about OCD treatment 
The five confidence ratings from the Pre Questionnaire were then repeated to assess for 
any change in confidence.  
Attendees were also asked to rate how well the day met their expectations (Very Well, 
Quite Well, Not Very Well, Not at all Well) and had the opportunity to expand on their 
answer with comments. Two other open questions asked what attendees would like to 
see in future professionals’ conferences, and how the OCD-UK team had made them 
feel welcomed. The TRBS was again included in order to assess any changes in OCD 
therapy relevant beliefs from pre to post conference day. 
 
Follow Up Questionnaire 
Follow up of professionals was conducted three months following the conference (end 
of January 2015). The aim of the follow up was to assess for the maintenance of belief 
changes over time, or any further modification/reversal of beliefs about OCD since the 
conference. Those participants who had given permission in the consent form were 
contacted via the email address they provided, and asked to follow a link to an online 
follow up questionnaire. Professionals were also asked to once again complete the 
confidence ratings, and were asked whether they felt they had made any changes in the 
treatment for OCD that they provided following the conference, and if so, what they 






The professionals’ day conference was aimed at those working therapeutically with 
individuals with OCD, and included therapists from a range of training backgrounds. 
The conference day had fifty-two attendees, which was significantly lower than 
originally predicted to attend.  Thirty-five of the attendees filled in both the pre and post 
questionnaires on the day. The largest group of participants were ‘high intensity 
therapists/CBT therapists’, but counsellors, trainee therapists and students also took 













Fig. 2.1: Frequency graph showing spread of participants’ professional roles.  
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Twenty-one of the attendees reported no personal experience of OCD, but six reported 
some personal experience. Two of the attendees described themselves as also being 
service users/people with personal experience or carers. The level of experience of 
participants in working with people with OCD varied, likely due to variations in roles 
and length of time working clinically. The majority of individuals who reported no 





2.6.1 Confidence Ratings 
The five clinician confidence ratings (working clinically with OCD, knowing evidence 
based treatments, assessing risk in OCD, working with families, and having insight into 
what it feels like to experience OCD) were checked for reliability and were found to 
have a good internal consistency (Cronbach’s α= .89). A total confidence rating from 
these five areas was calculated and compared from pre to post using paired sample t-
tests.  The results showed that clinician’s overall confidence in the above aspects of 
understanding and treating OCD had increased significantly from the start to the end of 
the Conference day (pre: M=7.47; SD=3.65; N=30; post: M=11.10; SD=2.26; N=30), 
t(29)= -7.72, p<.001).  
 
As well as the combined confidence ratings increasing significantly, further paired 
samples t-tests showed that participants’ confidence also increased significantly in each 
of the individual five areas of OCD understanding/treatment. See Table. 1 for means 
standard deviations and t-test results showing change in each confidence rating from pre 
to post conference. 
 
2.6.2 Beliefs Data 
The beliefs data was used to compute the six factors of the OCD therapy relevant beliefs 
scale (TRBS) (Stobie, 2009). One factor (Optimism) was altered slightly from that used 
in Stobie (2009) as question 20 was not included in calculating this factor. This was due 




Data were analysed to determine whether the OCD TRBS factor scores changed 
significantly from pre- to post-Conference.  A repeated measures ANOVA was 
completed, with Time (Pre/Post) and the six Beliefs Factors as the within-subjects 
factors. Maulchy’s test of sphericity was found to be significant for the interaction of 
Time by Beliefs Factor, so the Greenhouse Geiser calculation was used for this 
interaction. 
 
A repeated measures ANOVA revealed a main effect of Subscale (Belief Factor) 
whereby the ratings for each factor differed significantly, F(5, 110)= 112.59, p<.05, and 
a significant interaction between pre- and -post conference changes on the Beliefs 
Factors scores, F(5, 110)= 3.64, p<.05. The main effect of Time was not significant. 
 
As the interaction was significant, this was further explored with paired sample t-tests. 
These multiple comparisons indicated that two Beliefs Factors has changed significantly 
from pre- to post Conference, whereby Factor 1: Optimism had increased significantly 
(pre: M=80.14; SD=13.11; N=24; post: M=84.84; SD=11.60; N=24), t(23)= -3.38, 
p=.003), and Factor 2: OCD as a Biological Problem had decreased significantly (pre: 
M=-18.80; SD=14.54; N=32; post: M=-25.73; SD=11.87; N=32), t(31)= 4.04, p<.0001). 
Fig.3 shows the change in optimism factor and OCD as biological factor (transformed 
into belief in OCD as psychological to avoid negative values). 
 
Changes in the remaining four Beliefs Factors (Poor patient progress due to past life 
problems; OCD as a difficult problem with insufficient therapy; Perceived poor past 
therapy; OCD as a chronic problem intrinsic to personality) were not found to be 
significant. See Table.2 for details of mean changes and statistical outcomes for all six 
belief factors. New variables of total change in Beliefs Factors from pre- to post 
Conference were computed and again included in a Repeated Measures ANOVA. 
Maulchy’s test was again significant. The results confirmed the previous findings 
whereby there was a main effect of Subscale (Belief Factor changes); F(5, 110)= 3.64, 
p<.05. A correlational analysis was completed to assess for correlation between the two 
significant Beliefs Factors (Optimism and OCD as Biological). No significant 





Table 2.1: Table of mean pre and post confidence ratings and analysis results.  




SD t P 
Working 
Clinically 
31 1.29 .90 2.06 .68 -6.99 .000** 
Evidence Base 34 1.53 .82 2.44 .56 -6.41 .000** 
Risk Assessment 34 1.47 .96 2.15 .61 -5.77 .000** 
Insight into 
experience 
34 1.82 .72 2.47 .56 -4.45 .000** 
Involving Family 32 1.25 .95 1.91 .64 -4.72 .000** 
Note: **= significant to p<.001 
 
Table 2.2: Table of mean change and statistical outcomes for OCD beliefs factors. 




SD t P 
Optimism 24 80.15 13.11 84.84 11.60 -3.38 .003* 
Biological 32 -18.80 14.54 -25.73 11.87 4.04 .000** 
Past Life 
Problem 
24 34.48 22.67 29.33 24.63 1.18 .252 
Insufficient 
Therapy 
24 45.90 25.00 49.72 27.30 -1.24 .229 
Poor Therapy 24 34.17 18.80 39.26 23.71 -1.61 .121 
Chronic 
Problem 
24 17.15 14.42 11.31 12.77 2.01 .056 






Fig.2.3: Mean pre and post conference belief in OCD as psychological and optimism. 
 
2.6.3 General Conference Feedback 
Overall ratings of the conference day were extremely positive. As discussed earlier, 
attendees were asked to rate the content of the day on interest of topics; relevance to 
role/work; helpfulness for developing skills; positive impact on feelings about OCD 
treatment. The vast majority (96%) of overall ratings for the content of the day were 
either ‘very good’ or ‘quite good’.  
 
A frequency graph of ratings in each four areas can be found in Fig. 5, below. The day 
also appeared to successfully meet the expectations of attendees, with 83% of 
respondents indicating that the day met their expectations ‘very well’, and the remaining 
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Psychological and Optimism
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Fig.2.4: Frequency graph of ratings of conference content  
 
2.6.4 Follow Up 
Unfortunately very few professionals completed the follow up questionnaire (n=9 ), 
possibly due to technical issues accessing the form from some trust computers, which 
was not identified until after the final reminder was sent. This very poor response rate of 
follow up questionnaires meant that the data could unfortunately not be analysed 
statistically, however those who did respond continued to express positive comments 
about the day, and 8/9 stated that they had modified their treatment approach of OCD 
following the conference. 
 
2.7 DISCUSSION 
Although on paper people with OCD are offered appropriate treatment, something about 
how this is undertaken in practice appears to be leaving many feeling like their 
problems are not well understood. One potential explanation for this discrepancy is that 
many mental health professionals may hold biases and unhelpful beliefs about OCD and 
its treatment, which could negatively effect therapeutic alliance, adherence to evidence 
based treatment, and subsequent outcomes.  
This research has focussed on a one day professionals conference provided by national 
charity OCD-UK, inspired by reports of unhelpful treatment experiences from people 
with personal experience of OCD. Consultation with OCD-UK; professionals; and 














Ratings of content of training day for:
Not at all Good Not Very Good Quite Good Very Good No data
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and the event was also evaluated with questionnaires developed by the researches in 
consultation with OCD-UK.  
 
2.7.1 Strengths & Limitations 
Some limitations of the study are that although the beliefs questionnaire has been found 
to be reliable and valid in a patient format, the therapist format utilised has not yet been 
validated. Validation of this measure would be a potentially useful area of future 
research. Another limitation is a lack of useable follow up data, which prevents us from 
commenting on the longer term impact of the day. This is however something that 
OCD-UK could pursue in future Professionals Conferences. There is also the potential 
for expectation effects whereby individuals may have felt pressure to report a change in 
beliefs or to rate the day highly. However, these professionals had also paid money to 
attend the event, and therefore may be more likely to be honest and open should they 
have found the day to be less helpful. Finally, there was also a group of students who 
attended the day; and it is not clear if they were currently working therapeutically with 
individuals with OCD- however such students may in the future go on to work 
clinically, and any change in beliefs obtained is still likely to benefit individuals with 
OCD. Strengths of this research include the collaborative nature of the project with a 
service user group. The conference also represented an opportunity to get an insight and 
‘snapshot’ into current beliefs and biases held by mental health professionals about 
OCD, and has provided a more interesting and in-depth evaluation of the day than a 
basic feedback form would have been able to. 
 
The results found that attendees of the conference day reported significantly increased 
confidence ratings post conference in all of the five factors relating to understanding 
and treatment of OCD, such as confidence in knowing the evidence based treatments for 
OCD, and in completing risk assessments of intrusive thoughts in OCD. Importantly, 
participants also reported significantly increased confidence in having insight into the 
experience of OCD, and it is highly likely that the conference talks offered by people 
with personal experience played an important part in this, enriching the training day in a 
way that may not be the case in many non-service user led training events.  
 
Similarly to the results of Stobie (2009), the professional sample were found to hold 
varied beliefs about OCD, some of which are likely to be unhelpful in maximising 
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treatment effectiveness, such as belief in OCD as a largely biological rather than a 
psychological problem, or one that is chronic and linked to an individual’s personality. 
Encouragingly, even a one day conference day appears to have shifted some of these 
beliefs to a more positive stance, with statistically significant changes found in terms of 
an increase in optimism and decrease in belief in OCD as biological.  
These results are encouraging in suggesting that relatively brief training interventions 
can significantly alter professionals’ confidence and understanding of some of the more 
frequently troublesome areas of OCD treatment, such as intrusive thoughts 
unfortunately being viewed as evidence of actual risk (Glazier et al, 2013), as well as 
ensuring a good understanding of the current evidence base to avoid therapist drift and 
increase likelihood of successful treatment (Waller, 2009). 
The conference evaluation suggested that professional attendees highly regarded the 
conference day, with excellent ratings of the day and over 95% of attendees rating the 
day as either ‘good’ or ‘very good’ overall.  
 
This novel OCD-UK event was successful in significantly impacting both confidence 
levels and unhelpful beliefs about OCD and its treatment in a sample of mental health 
professionals. The feedback has been passed on to OCD-UK, who plan to run another 
professionals conference on a bigger scale in Autumn 2016. OCD-UK have requested to 
again utilise the beliefs and outcome questionnaires developed here to monitor change 
and evaluate subsequent professionals’ conferences, as well as to highlight areas of 
beliefs about OCD that they might not currently be addressing. This study also 
highlights the important role that service user groups could and should play in leading 
the way in the training and continuing development of mental health professionals, with 
uniquely engaging talks about personal experiences of OCD undoubtedly enriching the 
conference experience for all involved. 
 
2.8 SUMMARY OF MAIN POINTS 
1. A sample of mental health professionals were found to have varied beliefs about 
OCD, some of which were unhelpful and may have negatively impacted on 
treatment.  
2. A one day training event was found to significantly increase professionals’ self-
ratings of confidence in important areas of OCD understanding and treatment. 
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3. The training day also had a significant impact on professionals’ beliefs about 
OCD whereby optimism about treating OCD increased significantly from pre to 
post training, and belief in OCD as a biological rather than psychological 
problem decreased significantly pre to post training. 
4. This successful training/conference day held by OCD-UK supports continued 
collaboration between service-user led organisations and mental health 
professional training, which may represent a powerful way to educate and 
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Objective: This study aimed to replicate previous findings regarding the influence of 
recovery style and attachment on engagement and help seeking within the context of 
first episode psychosis (FEP). It also aimed to explore self-compassion and shame as 
new potential moderators of engagement, and in terms of their relationship with 
attachment and recovery style.  
Design: A cross-sectional between groups design was used to compare ‘high’ and ‘low’ 
engagers on the key variables. Whole sample correlational analysis was also undertaken 
to further explore associations with self-compassion and shame in FEP. 
Methods: Twenty-two individuals with psychosis under the care of Early Intervention 
(EI) Services completed four questionnaires. Care Coordinators were subsequently sent 
a questionnaire on engagement to complete via secure email. 
Results: No significant group differences on the predicted variables were found, with 
only time in service reaching significance. Although non-significant, avoidant 
attachment did result in a small to medium effect size whereby ‘low’ engagers scored 
higher on avoidant attachment, and a trend towards more non-white individuals in the 
‘low’ engagers group was nearing significance. In the secondary analysis, avoidant 
attachment was associated with shame and problems help seeking, even when positive 
symptoms were controlled for. Anxious attachment was associated with lower self-
compassion and higher shame. None of the variables were significantly correlated with 
recovery style. 
Conclusions: The small sample size limits the conclusions which can be made, however 
it is of interest that no significant differences were found between the two groups on the 
expected variables. Although self-compassion and shame did not appear to effect 
engagement in this sample, strong and distinct associations were found between these 









Early intervention services are designed to engage and support individuals experiencing 
a first episode of psychosis (FEP), and have a growing evidence base for reducing 
hospitalisation, relapse and symptom severity (Bird et al, 2010). It is recognised that 
increased duration of untreated psychosis impacts significantly on later outcomes 
(Singh, 2007), however the engagement of individuals into such services can be 
challenging. 
Evidence suggests that a ‘sealing over’ recovery style (McGlashan, 1987) reduces 
engagement with services and increases risk of relapse (Tait, 2003) whilst ‘integration’ 
(McGlashan, 1987) predicts better outcomes (Thompson et al, 2003). ‘Sealing over’ is 
conceptualised as involving a fixed negative view of psychotic experiences, their 
minimisation, and an unwillingness to consider and explore their personal meaning. 
‘Integration’ meanwhile is seen as involving curiosity and reflection on the experience 
of psychosis, and the integration of psychosis into their wider life experiences 
(McGlashan, 1987). Recovery style can also vary over time, and has been linked to 
changes in psychological adjustment to psychosis (Tait, 2003).  
Attachment models (Bowlby, 1980) have also been applied to engagement and recovery 
in psychosis. Generally, insecure attachment represents a transdiagnostic vulnerability 
factor for much psychopathology (Dozier, Stovall-McClough & Albus, 2008), and in 
psychosis has been associated with ‘sealing over’ and lower engagement in services  
(Dozier, 1990; Korver-Nieberg et. al., 2014; Gumley et. al., 2014; Tait, Birchwood & 
Trower, 2003). A recent review of attachment and psychosis (Gumley et. al., 2014) 
included 8 studies which explored insecure attachment and engagement in services and 
reported effect sizes ranging from medium to large (r= 0.32 to r= 0.55). Attachment 
style is conceptualised as developing in early life and remaining relatively stable over 
time, meaning that the development of therapeutic approaches to attempt to modify 
attachment style directly is challenging. There is therefore a need to identify underlying 
mechanisms and other moderators of engagement which link to attachment style but 
represent additional targets of psychological intervention in order to encourage 
integration and engagement.  
Social mentality theory provides a theoretical framework of innate motivation systems 
which, when activated, organize a range of psychological functions such as attention, 
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emotion, cognition, and behaviour (Gilbert, 1997). Social mentalities also have a critical 
role in appraising threat, enhancing safeness, and in regulating affect. In this framework, 
psychosis is characterised by high threat processing (Freeman, 2002; Gumley et al, 
2010), and individuals experiencing FEP may be conceptualised as being particularly 
vulnerable to the threat of perceived shaming or stigmatising from others, as well as 
possible internal threats of self-criticism and negative self-evaluation (Birchwood et al. 
2007; Gilbert et al., 2001).  
Stigma, shame and engagement  
Many individuals experiencing psychological problems avoid engaging with mental 
health services due to fear of discrimination (public stigma) or due to internalizing 
negative stereotypes (self-stigma) (Corrigan, 2004; Clement et. al., 2015; Evans-Lacko 
et al. 2012; Vogel, Wade, & Haake, 2006). The experience of shame is strongly related 
to stigma and is considered its predominant emotional consequence (Hinshaw, 2007).  
As one of the ‘self-conscious emotions’ developed in childhood  (Muris & Meesters, 
2014), shame is increasingly recognised as a risk factor for a variety of psychological 
problems (Gilbert & Andrews, 1998; Stuewig & McCloskey, 2005), and has also been 
linked to more insecure attachment style (Wells, 1996; Gross & Hansen, 2000) and 
difficulty help-seeking (Rüsch et. al., 2013, Clement et. al, 2015).  
Like stigma, shame can involve both external and internal components. External shame 
is linked to concepts such as stigma awareness (Pinel, 1999), and is characterised by 
negative conceptions of how others view the self: as defective, unattractive, or 
vulnerable to attack (Gilbert & Andrews, 1998). Internal shame includes self-focussed 
attention, self-evaluation as ‘bad’ or as being flawed in some important way (Gilbert, 
2006). Shame is also associated with self-criticism, low self-compassion (Gilbert et. al., 
2008) and depressive rumination (Cheung, Gilbert, Irons, 2004).  
In social mentality theory, shame-proneness has been linked to a preoccupation with 
social ranking and to either submissive or aggressive behaviour as a response to loss of 
face or social standing (Gilbert, 2000; Gilbert et. al., 2001). The experience of psychosis 
in a society where stigma about the condition remains high could lead to such a 
perceived loss of social rank, and cognitive appraisals of psychosis involving loss of 
social role, shame and perceived low social status are common, and have been found to 
predict post-psychotic depression (Iqbal et al., 2000) and social anxiety in FEP 
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(Birchwood et al, 2007, Michail & Birchwood, 2013). It is hypothesised therefore that 
higher shame may also lead to more problems with help seeking and engagement in 
FEP. 
Compassion and psychosis 
Compassion focused therapy has specifically been developed for individuals with high 
levels of shame and internal self-criticism. Drawing on social mentality theory, it aims 
to reduce focus on social ranking and on potential threat from others, and instead 
activate cooperative, caring and affiliative processes towards self and others.  
Self-compassion, unlike self-esteem, does not imply self-evaluation or comparisons 
with others. It is instead conceptualised as a way of relating helpfully to oneself even in 
instances of failure or perceived inadequacy. Key elements of self-compassion include 
extending kindness and understanding to oneself rather than harsh self-criticism and 
judgment; seeing one’s experiences as part of the larger human experience rather than 
as separating and isolating; and holding one’s painful thoughts and feelings in balanced 
awareness rather than over-identifying with them (Neff, 2003, 2009). Compassion has 
begun to be accepted as an important factor within psychological health and wellbeing 
(Barnard & Curry, 2011), and may represent an important protective factor for a range 
of psychological problems (MacBeth & Gumley, 2012). Theoretically, one might expect 
individuals with psychosis and higher self-compassion to report a more integrated 
recovery style following psychosis, rather than a minimising ‘sealing over’ style. 
Researchers have recently begun to apply compassion based approaches to psychosis 
with some promising results (e.g. Braehler et al, 2013; Gilbert & Procter, 2006; 
Laithwaite et al, 2009). A case series of compassion focussed therapy for individuals 
with malevolent voices found participants initially experienced compassion as 
‘frightening and untrustworthy’, but over time were able to access compassion more 
successfully and reported their voices becoming more compassionate and less 
malevolent (Mayhew & Gilbert, 2008).   
 
An experimental study has explored the concept of fear of compassion in a high shame 
non-psychotic sample, and found increased heart rate and cortisol levels in individuals 
with insecure attachment and high self-criticism when asked to generate self-
compassionate imagery (Rockliff et al, 2008).  Social mentality theory would argue that 
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warmth and kindness, for example in the context of engagement with psychological 
therapy or a Care-Coordinator, may feel threatening and trigger feelings of distress, 
sadness and grief in individuals who are threat-focussed and may lack previous positive 
affiliative experiences in early life (Gilbert, 2009, Gilbert et al, 2011, Gilbert et al, 
2008). 
 
Despite growing interest in both shame and compassion in mental health research, and 
specifically in psychosis, no known study has thus far explored self-compassion in FEP, 
and only two studies have explored shame in FEP in the context of co-morbid social 
anxiety (Birchwood, 2007; Michail & Birchwood, 2013). This research therefore has 
aimed to explore for the first time levels of both shame and self-compassion in an FEP 
population. It has also aimed to explore the theoretical position that those who show 
more difficulty engaging with EI services will also show lower levels of compassion, 
higher levels of shame, and utilise more avoidant coping in the form of a ‘sealing over’ 
recovery style. As attachment style has consistently been found to be influential in FEP, 
and has also been linked in some literature with shame and self-compassion, the 
relationships between these variables and insecure (avoidant/anxious) attachment 
dimensions are also explored. 
 
3.3 HYPOTHESES  
Primary Hypotheses 
The primary hypotheses focused on variables predicted to be associated with 
engagement with services in FEP. Lower engagers with services were hypothesised to 
report (a) more avoidant attachment (b) less ‘integrated’ recovery style (c) lower self-
compassion and (d) higher shame. It was also hypothesised that shame and self-




Attachment style has frequently been recognised as influential in psychosis research and 
FEP. Relationships between attachment style, self-compassion and shame have not 
previously been explored in a FEP sample however. Secondary hypotheses for this 
research  predicted that avoidant adult attachment style would be associated with (a) 
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shame, (b) a more ‘sealing over’ recovery style, and (c) problems with the ‘help 
seeking’.  
 Anxious attachment was hypothesised to be associated with lower self-compassion and 
higher shame, but not with problems in help seeking. 
Self-compassion and shame have not previously been explored in relation to recovery 
style in FEP, therefore exploratory analyses were planned. It was predicted that a more 
‘sealing over’ recovery style would be associated with higher levels of shame and lower 
levels of self-compassion.   
3.4 METHOD 
3.4.1 Design 
A between groups cross sectional design was utilised for the main evaluation, with 
correlational components evaluated in the entire group. Participants were therefore 
divided into high and low engagement groups, and comparisons made between the two 
groups for the primary hypotheses.   
3.4.2 Measures 
Attachment 
The Psychosis Attachment Measure (PAM; Berry et al., 2006) is a self-report measure 
using a four-point Likert scale which assesses dimensions of anxious and avoidant 
attachment. Total scores are calculated for each dimension with higher scores indicating 
more insecure attachment style. The PAM has acceptable levels of internal consistency 
(Cronbach’s alpha from 0.70 to 0.86 for anxiety and 0.60 to 0.91 for avoidance) (Berry 
et al, 2008).  
Shame 
 The ‘Other as Shamer Scale’ (OAS; Allan, Gilbert, & Goss, 1994) is a self-report scale 
comprising 18 statements scored with a five-point Likert scale. Higher scores indicate 





The Self Compassion Scale (short form) (SCS-SF; Neff et al., 2003) is a 12-item self-
report measure of compassionate responding to oneself. The SCS-SF has demonstrated 
adequate internal consistency (Cronbach’s alpha ≥ .86 in all samples) and a near-perfect 
correlation with the long form SCS (r ≥ .97 all samples). 
Recovery Style 
The Recovery Style Questionnaire (RSQ) was developed as a brief self-report form of 
McGlashan's Integration Sealing Over Scale and consists of 39 statements, which are 
dichotomously rated (disagree/agree). Higher scores represent an increasingly 
‘integrated’ style of recovery. The RSQ has been shown to have adequate psychometric 
properties (Cronbach's alpha coefficient of .73 for total score, and test-retest reliability 
correlation coefficient of .81 (Berry et al, 2006)) and was validated against the interview 
version (Drayton et al, 1998). 
Engagement in Services 
The Service Engagement Scale (SES) is a 14 item measure consisting of statements 
about client engagement with services which are rated on a four point Likert scale. The 
measure consists of four subscales exploring availability, collaboration, help-seeking, 
and treatment adherence, and is designed to be completed by Care Coordinators. Higher 
scores indicate more problems with engagement. The scale has been shown to have 
good reliability, high internal consistency and retest reliability, including discrimination 
between criterion groups in an assertive outreach team (Cronbach’s α = .76-.90 for 
subscales) (Tait, Birchwood and Trower, 2002).  
Psychosis Severity 
The Clinical Global Impression Scale for Schizophrenia is a short severity scale for 
psychosis symptoms involving rating five symptom areas on a likert scale ('Normal, not 
ill' to 'Among the most severely ill'). This scale has been shown to have good reliability 
and validity (Cronbach's α > .70 for all dimensions except depressive dimension which 
was α = .64). Correlation coefficients with other much lengthier assessments of 
psychosis severity e.g. Positive and Negative Symptoms Scale are high (most above 
0.75; Tait, Birchwood, & Trower, 2002). 
3.4.3       Participants 
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A number of inclusion/exclusion criteria were set for involvement in the research: 
 All participants were required to be under the care of one of the identified EI 
services, and considered to be experiencing psychosis by the service. 
 Aged between 18 and 35 
 No primary diagnosis of substance misuse or organic disorders- although some 
use of substances/alcohol would not exclude individuals from the study. 
 In first year of contact with service (initial criteria that was later removed) 
 
Twenty-eight individuals were referred by Care Coordinators from Early Intervention 
services in North Somerset, South Gloucestershire, Bath, Bristol, and Gloucestershire. 
Twenty-two individuals (79%; 13 males and 9 females) were successfully recruited to 
the study. The majority of participants described themselves as White British (14/22), 
with a small number reporting other ethnic backgrounds: Mixed White/Caribbean (3); 
Black (2); British Asian (1); British Indian (1). Participant ages ranged between 18 and 
31 (mean 23) and none had a primary diagnosis of substance misuse or organic 
disorders.  
Initially, participants were recruited only if they were within the first year of contact 
with the EI service (as this was expected to be a time when difficulties with engagement 
may be most prevalent and where individuals may be struggling most to come to terms 
with their experiences). However, due to significant recruitment challenges, an 
amendment was obtained to remove this inclusion criteria in order to widen recruitment 
opportunities. The mean length of time in contact with the service was just under two 
years (22 months), and the mean duration of untreated psychosis prior to contact with 
services was 1.3 months (range 0-6 months). Care Coordinators were asked to specify 
primary and secondary diagnoses. Primary diagnostic labels reported were; Unspecified 
nonorganic psychosis (n=11); First episode psychosis (n=6); Drug induced psychosis 
(1); Schizophrenia/ ‘probable Schizophrenia’ (n=4). Four participants were reported to 















Fig.3.1: Consort Diagram of Recruitment flow 
3.4.4 Procedure 
Ethical approval was granted by the University of Bath and NHS Research Ethics 
Committee (Appendix D). Approval was also further obtained from individual trust 
Research and Development departments of Avon and Wiltshire NHS Trust and 2Gether 
NHS Trust (Appendix D). The study adhered to British Psychological Society Code of 
Human Research Ethics (2010).  
Visits were made to all five of the EI services involved and team meetings attended to 
describe the research. Care Coordinators were asked to pass a letter from the researcher 
and an information sheet (Appendix A-B) to eligible clients they are working with, in 
which those clients were offered the opportunity to take part in the research with brief 
details of the study.  Following a later amendment (see Appendix E), the researcher also 
attended some groups run by two EI services (e.g. Recovery groups, occupational 
therapy groups) to explain the research and distribute information about the study. Any 
group members interested in the research were asked to inform the staff member leading 
the group or their Care Coordinator, who again passed on their details to the researcher 
who contacted those interested via phone after at least 24 hours and provided further 
information. If interested, a face to face meeting with the individual was subsequently 
arranged at least 48 hours later, where full consent to take part was obtained before 
 Individuals referred to researcher by Care-
Coordinators. (N= 28) 
 
Initial telephone discussion (N= 24) 
Completion of research appointment  
(N= 22) 






cancelled prior to 
appointment 
 




completing the questionnaire pack (see Appendix C). For those recruited through a 
group setting, the researcher always contacted the participants’ Care Coordinator prior 
to arranging an appointment to check eligibility.  
Completion of questionnaires took around 20 minutes. Research meetings took place 
either in participants own homes or in an NHS setting, depending on the choice of 
participants. Participants were encouraged to request a break whenever needed, and 
were offered a small reimbursement of £5 for their time and contribution. Participants’ 
data was given a unique identifying code to preserve confidentiality. A full debrief was 
provided to participants following administration of the questionnaires. Participants 
were also provided with a debrief sheet which included contact details for their EI team, 
the crisis team, the researcher, and information on relevant websites e.g. anti-stigma 
campaigns, compassion for voices. The Care Coordinators of participants were 
subsequently sent the Engagement in Services and Psychosis Severity Questionnaires to 
complete and return. 
3.4.5 Power Considerations 
A large meta-analysis of internalized stigma (a different but related concept to shame) 
found moderate to large negative correlation with treatment adherence and a meta-
analysis of links between compassion and psychopathology found a large overall effect 
size (p= -0.61; Z= -34.02; p<.0001; MacBeth & Gumley, 2013). A recent review of 
attachment and psychosis (Gumley et al, 2014) included 8 studies which explored 
insecure attachment and engagement in services and reported effect sizes ranging from 
medium to large (r= 0.32 to r= 0.55). Given the sparsity of comparable studies looking 
at compassion and shame in FEP, an apriori power calculation to estimate required 
sample size has been completed but should be treated as tentative. In line with available 
reported effect sizes, a moderate to large effect size of 0.35 was entered into the power 
analysis. With significance level set as .05 and power at 0.80 a required sample of 
approximately 60 (30 in each group) was suggested, indicating that the current study is 
likely to be underpowered. 
3.5 RESULTS 
Prior to analysing data for the main hypotheses of this study, a comparison of the high 
and low engager groups in terms of demographic factors and other potentially important 
variables was completed. Duration of untreated psychosis (DUP); time in service and 
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overall severity of symptoms (including subscales of Positive, Negative and Depressive 
symptoms) were explored using Fishers Exact/Mann Whitney U (Exact). There were no 
significant differences in age, gender or comorbidity between groups. Ethnicity was 
nearing significance (Fishers Exact, p = .056) whereby there was a non-significant trend 
towards a higher proportion of non-white participants in the low engagers group. All 
other results were non-significant with the exception of duration of time in service, 
whereby high engagers had been in contact with services for longer than low engagers 
(U = 23.00, Z=  -2.46, p = .012). See Table 1 for further details of demographic and 
service related variables. 
 
Table 3.1: Participant demographic and service related data. 
 High Engagers N=12 Low Engagers N=10 
Gender: Male/Female 6/6 7/3 






Ethnicity: White British (91.7%) 
Other (8.3%) 
White British (50%) 
Other (50%) 
Comorbidity present: 33% 33% 
Service: Bristol 25% 




South Glos 40% 
Bath 10% 
North Somerset 10% 
DUP (months): M (SD) 0.91 (SD 0.99) 1.9 (2.07) 
Time in Service: M (SD) 29.25 (17.98) 15.70 (6.61) 
Severity: M (SD) 10.33 (4.90) 10.25 (5.35) 
 
3.5.1 Engagement 
The SES is reported to have a bi-modal distribution, with little overlap in scores 
between reported High and Low engagers in the original study (High: M 4.7, SD 5.4, 
range 0-13; Low: M 19.7, SD 9.10, range 6-29, Tait, Birchwood & Trower, 2002). A 
similar pattern was found in this data with clustering of scores either below 7 or above 
10. Individuals scoring 7 or below were therefore considered ‘high engagers’ and those 
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scoring 10 and above ‘low engagers’.  Twelve high (M 3.08, SD 1.97, range 0-7) and 
ten low engagers (M 15.55, SD 3.83, range 10-21) were identified.  
Split groups analysis was used to explore variables for normality. No severe skewness 
or kurtosis was present, and Kolmogorov-Smirnov tests were not significant. Despite 
this, non-parametric tests (Mann-Whitney U) were utilised due to the small sample size. 
The primary hypothesis was explored by comparing group differences between high and 
low engagers on variables of self-compassion, shame, recovery style, avoidant 
attachment style and time in service (see Table 2 for Means and Standard Deviations). 
The ‘Exact’ test p values were utilised to determine significance due to its increased 
accuracy with small sample sizes. 
No significant group differences on the predicted variables were found, with only time 
in service remaining significant (U = 23.00, Z=  -2.46, p = .012) with a small effect size 
(r = -.11). Although non-significant (U = 43.5, Z = -1.094, p = .144 (one-tailed)), 
avoidant attachment did result in a small to medium effect size (r = -0.23). Due to the 
small sample size and lack of significant differences between high and low engagers, 
the planned regression analysis was not completed. 
Table 3.2: Median (Mdn) and Range (R) scores of High and Low Engagers 
 
3.5.2 Attachment style 
A correlational analysis was used to explore the secondary hypotheses around insecure 
attachment dimensions and predicted associations. The avoidant attachment and anxious 
attachment variables; shame; self-compassion; recovery style and help seeking 
problems were checked for normality. All had acceptable levels of skewness and 
kurtosis, and Kolmogorov-Smirnoff was not significant for any of the variables. A 
Pearson Correlation was therefore utilised. Psychosis symptom dimensions (positive or 




Self-Compassion (SCS): Mdn (R) 2.87 (1.92) 3.04 (2.75) 
Shame (OAS): Mdn (R) 27.50 (48.00) 26.00 (31.00) 
Recovery Style (RSQ): Mdn (R) 76.90 (30.50) 76.90 (54.00) 
Avoidant Attachment (PAS): Mdn (R) 1.31 (1.75) 1.62 (1.75) 
Time in Service (Months): Mdn (R) 10.00 (14.00) 8.00 (14.00) 
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negative symptoms) have frequently been associated with attachment style in previous 
research, so these variables were explored for any significant associations with 
attachment in this sample. Positive symptoms were found to correlate significantly with 
avoidant attachment.  
a) As predicted, avoidant attachment was positively associated with shame and 
problems with help seeking. Contrary to expectation however, the small to medium 
correlation of avoidant attachment with integrated recovery style was not significant. 
When positive symptoms were controlled for in a partial correlation, avoidant 
attachment remained significantly and strongly associated with help seeking problems 
but the remaining medium effect size of shame was no longer significant. See Table 3.3 
for statistical figures. 
b) As predicted, anxious attachment was negatively associated with self-compassion  
and positively associated with shame. As self-compassion and shame are theoretically 
closely related and were also highly correlated, partial correlational analysis were used 
to further explore the associations as reported above. Shame remained significantly 
correlated with anxious attachment (but to a lesser extent) when controlling for self-
compassion. When controlling for shame, self-compassion was no longer significant. 
See Table 3.3 for statistical figures. 
Table 3.3: Pearson Correlation Coefficients for secondary hypotheses  
Variables 1 2 3 4 5 6 7 
1. Self-Compassion _       
2. Shame -.646** _      
3. Problem Help Seeking .297 -.090 _     
4. Integration (RSQ) .185 -.189 -.130 _    
5. Positive Symptoms -.461* .403 -.209 .123 _   
6. Anxious Attachment -.620** .706** -.199 -.012 .254 _  
7. Avoidant Attachment -.215 .505* .427* -.234 .455* .205 _ 
*Correlations significant to p < .05 level (two-tailed). 
**Correlations significant to p < .01 level (two-tailed). 
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 3.6.3 Compassion, shame & recovery style 
A Pearson correlation was completed to explore associations between variables and to 
test hypothesis 3. Shame was found to be significantly and strongly negatively 
associated with self-compassion, however contrary to predictions neither shame nor 
self-compassion were significantly correlated with recovery style. See Table 3.3 for 
statistical figures. 
3.6 DISCUSSION 
This research aimed to replicate previous findings regarding the relationship between 
insecure attachment, sealing over recovery style and engagement in services, as well as 
explore the potential role of more novel factors drawn from social mentality theory; 
namely self-compassion and shame. As self-compassion had not previously been 
measured in an FEP sample, and shame had only been measured in two previous 
studies, the associations between these variables and attachment and recovery style were 
also explored.  
Engagement 
The comparison of high and low engagement groups did not find any significant 
differences in the expected variables of recovery style, attachment, self-compassion or 
shame, with the only significant between groups difference being longer time in service 
in the high engagement group, suggesting (as would be hoped) that the quality of 
engagement with services improves over time.  
It is surprising that no significant relationship was found between avoidant attachment 
and engagement, as a number of previous studies have successfully linked avoidant 
attachment with engagement related variables, such as poor help seeking and poor use 
of treatment (Dozier, 1990) and poorer therapeutic alliance (Berry et. al., 2008). Secure 
attachment has been associated with overall engagement in services (MacBeth et. al., 
2010), treatment adherence (Dozier, 1990, MacBeth et al, 2011) and reduced likelihood 
of disengaging (Tait, Birchwood & Trower, 2004). The lack of significant relationships 
between avoidant attachment and engagement in this sample may be due to the small 
sample size and subsequent lack of power, as although non-significant, a small to 
medium effect size for avoidant attachment was present. A variety of different measures 
of attachment have also been utilised in previous research including narrative 
approaches e.g. Adult Attachment Interview, as well as a range of self-report measures 
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(including the PAM utilised here), which may result in differing attachment dimensions 
that may relate slightly differently with engagement.  
Although it has successfully been linked to attachment in the past (e.g. MacBeth et. al., 
2011), another factor may be the broad nature of the SES engagement questionnaire 
utilised in this study.  Engagement itself is clearly a highly complex area, and a range of 
engagement related subscales make up the overall SES score. These include questions 
around availability for appointments and medication adherence, with less emphasis on 
more subtle interpersonal factors than measures of therapeutic alliance, for example. It 
is of interest that in this study the help-seeking subscale of the SES in particular was 
significantly associated with avoidant attachment in the secondary hypotheses, the 
results of which will be discussed in more detail below. Finally, although previous 
studies have found associations between adult attachment and key worker relationships 
(Berry et al, 2007), suggesting that ratings of close relationships in general are 
meaningful in conceptualising relationships to professionals, the extent to which the 
psychiatric staff in this study represent attachment figures to the participants is 
unknown. 
There is less available research exploring the influence of recovery style on 
engagement, however a more sealing-over recovery style has also been associated with 
insecure attachment (Tait, Birchwood & Trower, 2004), and sealing over at 3 months 
post psychotic episode significantly predicted engagement as measured by the SES at 6 
months (Tait, Birchwood & Trower, 2003). One possible reason for a lack of significant 
effect in this sample is that the majority of participants reported a more integrated 
recovery style, with only one participant falling within the highest possible category of 
‘predominantly sealing over’ recovery style, thereby limiting the ability to detect a 
relationship with engagement (or with self-compassion and shame in the secondary 
analysis). Although there was a wide range in engagement scores in this sample, the 
mean score of the low engager group was less than the low engager group in the SES 
validation study; so the most difficult to engage individuals (and perhaps those with 
more extreme sealing over style) may not have agreed to take part in this study. Another 
potential reason for less ‘sealing over’ in this sample may be due to widening of the 
inclusion criteria beyond individuals in their first year of contact with services. Several 
studies (Thompson et al, 2003; Tait, Birchwood & Trower, 2003), found the recovery 
style of their FEP sample shifted over the first 6 months/year of treatment, generally in 
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the direction of increased integration. The shortage of individuals during earlier phases 
of treatment may have contributed to the predominance of integration in this study.  
It is surprising how similarly the high and low engagement groups scored on the 
variables of self-compassion and shame. Although theoretically it would be expected 
that those with higher shame would struggle to engage and seek help, such a 
relationship was not found in this sample. It would have been of interest to be able to 
compare a measure of more internal shame with the more external shame measure 
utilised here; however one would expect self-compassion to relate to internalised shame, 
and self-compassion also had no association with engagement. Social mentality theory 
proposes that threat based mentalities may lead to either an aggressive/rejecting stance 
or a submissive reaction. It may be therefore that a proportion of those experiencing 
shame in this sample responded submissively and therefore would be relatively easy to 
engage (but may not engage in the most helpful way). It would be of interest in future 
research to assess for any relationship between self-compassion and shame and more 
subtle/interpersonal engagement related variables, such as therapeutic alliance or 
therapy interfering behaviours.  
Factors about the services themselves and its staff (which were not explored in this 
study) are clearly variables that may greatly influence an individuals’ ability to engage. 
The identified non-significant trend towards more non-white individuals in the low 
engagement group is potentially important. Although no strong conclusions can be 
drawn from this data alone, they may hint at a need for services to ensure they are 
meeting the needs of individuals from minority ethnic and cultural backgrounds in order 
to maximise their engagement.  
Self-Compassion, Shame & Attachment Style 
Attachment style has frequently been explored in psychosis samples, with findings that 
individuals with psychosis/schizophrenia are more likely to have insecure attachment 
styles than individuals with affective disorders (Dozier, 1990), and that insecure 
attachment can predict key worker and parental relationships (Berry et. al, 2007); and 
has been linked to psychosis symptomatology (Wickham, Sitko & Bentall, 2014).  
Although (as we have discussed) avoidant attachment was not significantly associated 
with engagement as a whole, it was significantly associated with the help seeking 
subscale of the engagement questionnaire, replicating previous findings (Dozier, 1990). 
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This subscale involves questions around seeking help when in a crisis or individuals 
contacting their Care Coordinator on their own impetus when things become difficult to 
avert worsening of symptoms. Such actions are arguably some of the most important in 
terms of managing risk and reducing the chances of relapse, and it is therefore of 
interest that individuals with more avoidant attachment may require additional support 
around seeking help when needed. Avoidant attachment was also significantly 
correlated with external shame as predicted, supporting the conceptualisation of 
avoidant attachment as representing a tendency to view others negatively e.g. as 
judgemental or critical.  Anxious attachment is conceptualised as involving a tendency 
to view the self negatively, and to fear abandonment from others. As predicted, anxious 
attachment was found to be associated with high levels of shame and low levels of self-
compassion, but was not associated with problems help seeking.  
3.7 STRENGTHS & LIMITATIONS 
A limitation of this study is the fairly concrete definition of engagement measured by 
the SES questionnaire. Although useful, the focus on practicalities e.g. making and 
attending appointments, likely oversimplifies the complexity of both defining and 
measuring engagement in a meaningful way. A measure which also explored more 
subtle interpersonal factors such as working alliance (e.g. Working Alliance Inventory: 
WAI, Horvath & Greenberg, 1989) may have produced further interesting results. 
Engagement is also dyadic, however the SES measure is clinician-rated, and does not 
explore patient views or staff and service related variables which may impact 
engagement. A relatively new measure of engagement in psychosis (SOLES: O’Brien, 
White, Fahmy & Singh, 2009) may have been a beneficial addition as a patient report 
measure which has been validated in psychosis samples. Finally, due to the need to 
widen recruitment beyond the first year of contact, there are indications that the sample 
acquired was relatively stable and with a more integrated recovery style, limiting the 
ability of this study to identify the impact of more sealing over perspectives.  
Strengths of this research include the use of novel measures in a FEP sample e.g. shame 
and self-compassion, and the identification of strong associations between these 
variables and attachment. The feedback from participants was also highly positive, with 
reports that the research had made them think and reflect on some of their beliefs e.g. 
about psychosis. The drop-out rate in this sample was also low, suggesting good 
acceptability of the research to participants. 
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3.8 CLINICAL IMPLICATIONS 
Whilst research has shown strong links between adult attachment and psychosis, little is 
known about the mechanisms which may underlie these relationships. Further 
exploration of shame and self-compassion as potentially important factors relating to 
attachment style in FEP samples could help identify areas for future intervention. The 
use of short adult attachment self-report measures could help services to identify 
individuals with differing attachment styles that may benefit from slightly different 
approaches from EI teams. Although further research is required and a link with more 
general engagement was not found, there is some evidence supported by this study that 
individuals with psychosis and a more avoidant attachment style may need extra support 
around help seeking in particular (e.g. during a time of difficulty or crisis). Further 
research into the possibility that a more anxious attachment presentation in FEP may 
represent a risk factor for low self-compassion and more shame could also lead to more 
tailored interventions. The use of attachment style by services has the potential to lead 
to modifications in approach which could better meet the varying needs of individuals 
with FEP and hopefully maximise the helpfulness of the service.   
3.9 RESEARCH IMPLICATIONS 
Although attachment style has frequently been explored in psychosis samples, the 
relationship of these variables with self-compassion and shame has not previously been 
explored in a FEP sample. The fact that attachment dimensions were significantly 
correlated with self-compassion and shame in the directions predicted even in this small 
sample, and when using a short self-report measure rather than more detailed and 
lengthy adult attachment interview (AAI) suggest that further research into these 
relationships is important.  
Due to the limitations of power in this small sample, further replication of results would 
be required, particularly the somewhat surprising negative results concerning the lack of 
a relationship between predicted variable and engagement. As discussed previously, 
further research exploring more subtle and interpersonal engagement in FEP would also 
be beneficial, and continued development of a meaningful definition of engagement 





This study aimed to replicate previous findings regarding the influence of recovery style 
and attachment on engagement and help seeking within the context of first episode 
psychosis (FEP). It also aimed to explore self-compassion and shame as new potential 
moderators of engagement, and in terms of their relationship with attachment and 
recovery style.  
The small sample size limits the conclusions which can be made, however it is of 
interest that no significant differences were found between high and low engagers on 
the expected variables. Although self-compassion and shame did not appear to effect 
engagement in this sample, strong and distinct associations were found between these 
variables and insecure attachment dimensions, indicating a possible area for further 
exploration, particularly as some dimensions were associated with difficulty accessing 
help in a crisis. With further replication, these findings have implications for Early 
Intervention services that may wish to utilise short self-report attachment measures to 
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Early intervention (EI) services provide evidence-based support to individuals 
experiencing a first episode of psychosis (FEP) (Bird et al, 2010). A key aim of EI 
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services is to engage people and support them to get help, as there is strong evidence 
that a longer duration of untreated psychosis (DUP) can lead to poorer long-term 
outcomes compared to those who get help quickly. However those experiencing FEP 
vary in their help-seeking behaviour. When people feel threatened, they may find it hard 
to trust others and to ask for help. 
There is strong evidence that someone’s early experiences of being cared for can affect 
how easy it is for them to trust others later in life and to open up to other people. Those 
who received good and stable care in childhood often feel OK about themselves and 
think others are generally trustworthy (this is called secure attachment). However if 
early care was not ideal, was inconsistent or confusing, this can lead people to struggle 
to trust and open up to others (insecure avoidant attachment) and/or can lead to feelings 
of inadequacy and anxiety that others will abandon them (insecure anxious attachment).  
Previous research has found that factors such as an insecure avoidant attachment style 
and a ‘sealing over’ recovery style (minimising and shutting away psychosis 
experiences) have been associated with more problems help-seeking, engaging with 
services, and poorer outcomes.   
 
This research aimed to see whether these results could be replicated, but it also wanted 
to explore other factors that may link to engagement. Despite growing interest in self-
compassion and shame in the context of psychosis, no previous study has measured 
self-compassion in an FEP sample, and only a handful of studies have explored shame. 
The relationships between these variables and the more established factors in psychosis 
samples (insecure attachment style and recovery style) were therefore also be explored. 
 
People with psychosis being seen by EI services completed questionnaires, and their 
Care Coordinators from the service were asked about how easy or hard they felt the 
person was to engage. No significant differences were found between those who were 
easier and harder to engage overall on our measures of attachment, integration, self-
compassion or shame. Those who were harder to engage did score higher for insecure 
avoidant attachment, and there were more non-white people in this group but both these 
trends were not statistically significant. It was found that those who engaged more had 




An exploration of attachment in more detail found that avoidant attachment was 
associated with difficulty asking for help in difficult times, and higher shame. Anxious 
attachment was also associated with shame, and also lower self-compassion. These 
findings fit with the pattern we would expect from attachment theory. 
 
It is hoped that these findings might encourage other researchers to explore further how 
individuals’ different attachment styles may affect how they cope with having 
psychosis, how they think others see them, and how they view themselves in the context 
of FEP (e.g. self-compassionately or not). It is possible that in the future services could 
tailor their approach to suit an individuals’ attachment style in order to best support 

























5.1 LITERATURE REVIEW 
 
My literature review was inspired directly by a lady I worked with in my older adult 
placement (I also wrote up this therapeutic work in Case Study 2). She had Parkinson’s 
disease (PD), and was also suffering with panic attacks. Her doctors had prescribed her 
antidepressants and had informed her that panic attacks are very common in PD. She 
was under the impression that her doctors felt the panic was simply a common symptom 
of the neurological effects of PD, and that it was unlikely they would get any better. She 
felt distressed that she was expected to just ‘live with it’ along with all the other 
challenges and motor symptoms. Through talking to her I realised that although 
complicated by her PD symptoms, and often triggered by them, her panic was also 
comprehensible through the cognitive behavioural model. We commenced a slightly 
modified CBT intervention for panic; her panic decreased and her mood lifted. No one 
had previously explained to her what panic was, that it was not dangerous, and that lots 
of people without PD also experience it.  
Albeit pleased with the outcome of treatment, my client was also frustrated by the 
unnecessary anxiety she had experienced through a complete focus on the medical 
management of PD and a lack of acknowledgement of additional psychological needs. 
When my initial literature review proposal (about vagal tone and other physiological 
links to psychopathology) was deemed unwise due to a lack of high quality papers, I 
refocussed on this issue that had struck me through my clinical experience. I therefore 
decided to focus on trying to write the review I had wished I could find when I first 
started working with my panic patient.  
 
I soon realised that research into anxiety in PD was still limited; and there was 
insufficient research to focus specifically on panic. The topic therefore widened to 
include anxiety in general within the context of PD. I looked into existing reviews and 
with the support of James Gregory my supervisor developed an idea of what was 
missing; a review of evidence for a more psychological perspective on anxiety in PD, 
and possibly even a model to further illustrate a psychological conceptualisation. After 
several months of refining and literature searches, James suggested inviting Dr Leon 
Dysch (Neuropsychologist) to get involved, as a clinician working in a 
Neuropsychology service and with insight into the particular client group. As the review 
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was primarily aimed at supporting clinicians, it felt useful to have a clinician on board 
to ensure the review remained relevant to practice. Following a useful meeting with 
Leon and James, and also a discussion with a Consultant and Doctor involved in 
Movement Disorder services in Bath in September 2015, the focus of the review finally 
came together. From now on it was a case of reviewing 30 papers in detail, summarising 
them and starting to organise and synthesize the results. I found writing the lit review 
probably the most challenging of all my research write ups. I found the process very 
time consuming and complex due to the need to try and absorb and analyse what felt 
like a huge amount of information, and then produce a coherent outcome. What I found 
most challenging was the need to fit in my literature review work on odd days or hours 
when I had time; it was really hard to write without a large chunk of time to dedicate; at 
times it felt like one step forward and two back. On reflection the neuropsychology 
topic probably added an additional challenge, as it required considerable learning ‘on 
the job’ about PD as a disease. It was really helpful however to end up on placement 
with Leon in my first elective placement, as this allowed me to gain additional 
neuropsychological understanding.  My interest in developing a model also greatly 
increased the challenge- and there were times when I wished I had not suggested it! 
However I am very pleased and satisfied to have included a model which I know I 
would have found helpful and encouraging at the time of the clinical work that inspired 
the whole project. I would have really struggled (even more) to complete this review 
without the vital periodic support of both James and Leon, who despite many demands 
on their time, have been reliable and timely in their review of drafts, and who have 
offered (at times much needed) encouragement. 
 
5.2 SERVICE IMPROVEMENT PROJECT 
 
My service improvement project stemmed from my interest in service user groups and 
the potential of such organisations to enhance and energise clinical practice and NHS 
services. An opportunity arose through Prof Paul Salkovskis to get involved with OCD-
UK; a service user group and national charity of people with personal experience of 
OCD designed to offer support, accurate information and advice to OCD sufferers and 
their family and friends. Paul had been involved with the organisation for many years, 
and regularly spoke at their Annual Conference for people living with OCD. However 
OCD-UK had discussed with Paul their concerns that they continued to hear distressing 
accounts of the poor understanding of many therapists about OCD and the misleading 
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information or unhelpful treatments that were still offered. OCD-UK had decided they 
wanted to do something about this; by adding an additional day to their Annual 
Conference aimed at mental health professionals. OCD-UK wanted help with this 
however; to help decide on what topics would be most important to include, and to find 
a way to somehow evaluate the day to assess whether this addition to the Conference 
was successful, and whether it would be something they should continue. A fellow 
trainee also became involved with a parallel project of introducing an evaluative 
component to the standard Conference day for people with OCD.  
 
I was introduced to Ashley Fulwood (Director) and another OCD-UK and Conference 
team member via Paul initially, and ‘met’ with them both regularly via skype to plan 
and implement the project. Initially this involved collecting information about what 
topics would be useful at the professionals day- through a brief questionnaire posted on 
mental health professionals’ websites and the OCD-UK forum for a service user 
perspective. Responses were then summarised and sent to OCD-UK to help shape the 
day. Some topics appeared particularly urgent, such as training and advice on risk 
assessment of intrusive thoughts (which if misinterpreted can lead to distressing 
intrusive thoughts being taken as evidence of risk e.g. to others). Alongside this began 
the development of a way to evaluate the new conference day. In consultation with 
OCD-UK we identified the key general feedback they required, including ratings of 
interest, relevance of topics etc, but also wanted to attempt to gather more meaningful 
data about any change in beliefs or attitudes of attending professionals. Helpfully, Paul 
had previously supervised a PhD which had involved the development of a therapist 
beliefs scale about OCD. With some minor adaptations this scale was incorporated into 
a ‘Pre’ and ‘Post’ questionnaire for conference attendees. Following final consultation 
with OCD-UK and minor revisions, myself and the other trainee involved with the 
service user conference set off to Nottingham for the Conference. On the professionals 
day, Ashley (who was starting the day off with a brief introduction) encouraged 
professionals to complete the forms and explained their importance, the final speaker 
also reminded attendees to complete their ‘post’ questionnaires. Attending the 
conference was a real highlight- the quality of speakers was fantastic and included not 
only well known researchers in the field, but also personal stories and insights from 
people with their own very personal understanding of OCD. It was a fantastic example 
of true collaboration between ‘service users’ and ‘professionals’ that helped me to see 
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how the barriers and sense of ‘them and us’ which so often sadly occurs can be broken 
down; and that when this does happen, it empowers both groups.  
 
It was unfortunate that the numbers attending the professional’s day were fewer than 
expected (largely due to delays in advertising the event). However a large percentage of 
those that attended did complete the questionnaires, and I was able to provide OCD-UK 
with highly positive feedback from professionals. The day appeared to be a great 
success, with very high ratings on all aspects. Even more proof of this perhaps was that 
significant and positive change was found in the professionals’ beliefs about OCD- after 
only one day of lectures and discussion. It was fantastic to see that factors like therapist 
confidence about treatment and optimism about working with OCD improved- and it 
felt particularly meaningful that the whole event was initiated, planned and developed 
by experts through experience, rather than experts by position or training. I feel this 
project has encouraged and strengthened my interest in service user involvement, and 
likely influenced my later involvement with the People with Personal Experience 
Committee at the University, and the subsequent consultation project for that committee 
on service user involvement on training programmes. I hope to continue working with 
service users to benefit and shape research and services long into my future career. 
 
5.3 MAIN RESEARCH PROJECT 
 
My main research project was also influenced by clinical work, this time in my first 
placement where I experienced working with people with psychosis, and was 
introduced to an approach than has gone on to influence me greatly; Compassion 
Focused Therapy (CFT).  When learning about CFT and seeing it in practice through a 
group intervention, I immediately became fascinated with the transdiagnostic nature and 
power of self-compassion and its polar opposite, shame.  
My initial research ideas were around whether high shame and low self-compassion 
might predict those at higher risk of post psychotic depression; however this would 
involve a significant follow up period, and was therefore unrealistic in the timeframe 
available. I then met with a member of staff with an interest in CFT research, who 
introduced the idea of looking at shame and self-compassion in oncology patients- an 
area where he worked clinically. However when this tutor ended up leaving the course, I 
returned to my original focus on psychosis. 
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After meeting with Lorna Hogg to discuss different ideas, I started to read current 
literature on compassion, shame and psychosis. I became interested in social ranking 
theory, and how this could be applied to a research study. Clear themes from available 
literature on psychosis became apparent and I started to develop a hypothesis that drew 
on social ranking theory about how self-compassion, shame, attachment and recovery 
style might relate to each other and to engagement in psychosis services.  
With advice from my supervisor, I anticipated from the start difficulty in recruiting 
people with psychosis from Early Intervention (EI) services. For this reason I contacted 
and included six EI services in my ethics application. I found the process of obtaining 
ethical approval extremely slow, frustrating and complex, and there was little guidance 
available because the process appeared to have changed since the last cohort of trainees. 
Despite these difficulties, the research passed through proportionate review by early 
April 2015. This felt very early, and I was hopeful that I had given myself plenty of 
time, however once I contacted R&D, I was told that the EI services should have been 
listed as research sites, not SIPs. Although a small error, AWP R&D required an 
amendment form to be completed, which took many weeks to process and delayed 
recruitment starting for two months. Final approval was gained on 8th July 2015.   
Despite using the delay to get back in contact with all the EI services, the psychologists 
in the teams, and attending meetings to inform about the study, recruitment was (and 
would continue to be) very slow. Despite getting a list of all service users in their first 
year and then sending personalised emails to each individual Care Coordinator about 
those on their caseload, only four participants had been referred from the five services 
currently involved by the end of September 2015. It was clear that my initial restriction 
to individuals in their first year of contact with services was further reducing my 
chances of recruitment.  
I therefore decided to remove this restriction to widen my opportunities, and also to 
allow me to organise joint research appointments with another trainee recruiting from EI 
services- so that we could complement rather than compete with each other. A further 
amendment was therefore submitted, again taking several weeks, being completed in 
November 2015. Although referrals picked up slightly following this, partly due to 
frequent reminders to teams and individuals within the services, referrals ground to a 




In discussion with teams and my supervisor, myself and the other trainee both submitted 
yet another amendment to be able to attend groups run by the EI services to distribute 
information directly to service users. Again after several weeks this was approved at the 
end of February 2016. Although only two of the services were currently running groups, 
we were able to attend several, and this resulted in a final modest flurry of participants, 
some of whom were recruited directly by us, and others who were referred by Care 
Coordinators we met at the groups.  
Despite two amendments to modify approaches, countless emails of encouragement and 
requests, and linking in with key individuals within teams, recruitment to this research 
project has been hugely challenging. Ironically, or those referred, the number of 
participants refusing to take part or not responding to contact was extremely low. It felt 
that the main barrier to recruitment was Care Coordinators feeling overworked, 
overwhelmed and unable to dedicate time and energy to research. The period of my 
recruitment may have been particularly challenging due to simultaneous changes to 
targets and goals required by EI services (first contact with new referrals needed to 
happen faster, and starting to also work with ‘at risk’ clients) at a time when resources 
and staffing was tight. Although understandable, the impact on research has been 
frustrating and at times disheartening.  
 
Despite not being able to reach my recruitment target (and thereby limiting my 
statistical power), I have really enjoyed conducting this research. Meeting individuals 
face to face allowed the research to feel much more personal, and I hope made 
participants feel more valued and listened to, due to opportunities for discussion and 
reflection. Feedback from participants has been very positive, with some reporting that 
the questionnaires had encouraged them to think about things differently, such as how 
little compassion they may give to themselves. Although some participants found the 
process tiring, none of the participants appeared or reported being emotionally upset or 
distressed by taking part, and it was a pleasure to meet every one of them. 
 
5.4 CASE STUDIES 
 
I have referenced several of my case studies already above, as my clinical work has 
often helped to inspire and direct my research interests. I believe that the process of 
writing up clinical work has ensured reflection and wider consideration of the heuristic 
value of therapeutic experiences. I hope that I will carry forward this curiosity and drive 
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and continue to be inspired by the people I work with to explore further research 
opportunities, such as writing up future clinical work or introducing evaluation and 
outcomes to group interventions. I would also like to add to the growing evidence base 
for third wave CBT therapies (such as Compassion Focussed Therapy), and to be 








































APPENDIX A- Research Invite Letter 
Hello.  
Thank you for taking the time to read this letter!   
My name is Emma Stephens, I am a trainee Clinical Psychologist,  
studying at Bath University and working in the NHS. This is me!  
 
I am writing wondering whether you might be interested in some 
research I am doing.   Your Care Coordinator kindly agreed to pass this 
letter on to you.  If you think you might be interested I’d be very happy to arrange a convenient 
time to ring you and we could talk more about it. 
My research 
Through working with people who are going through hard times, I have become really 
interested in how we all cope with difficult experiences in our lives, and whether we are 
hard/critical or kind to ourselves when things may be tough. 
I am really interested in whether the different ways we all deal with our experiences can make 
asking for and receiving help and support (e.g. from NHS services or friends/family) easier or 
harder.  
I would really like to meet with people who are attending the Bristol service for a short 
individual interview (30min- 1hour) to fill out some questionnaires together. The questionnaires 
are about: 
 Recovery style (which is the way people cope with difficult experiences) 
 Attachment style (how someone relates to and feels towards other people) 
 How people feel about themselves in difficult times (self-critical or kind and 
understanding). 
Taking part in the research would be completely optional.  It is totally your choice whether or 
not you’d like to take part.  Whatever you decide is absolutely fine and of course will not affect 
your care in any way.   
What would happen next? 
 If you think you may be interested, I wonder if you could kindly let your Care 
Coordinator know and s/he will pass the message onto me.  I would then ring you some 
time the following week to arrange a convenient time to chat. 
 On the phone I could answer any questions you may have and if you decide you would 
like to go ahead we would then arrange a convenient time to meet up (normally your 
home).   
 At the meeting we would go over the details of the research and I would check that 
you’re still happy to go ahead.  If so we would then complete the questionnaires 
together.  I estimate this would take about 45 minutes (but it could be a little more or 
less) 
 You would receive £5 as a small token of appreciation for your time and energy in 
completing the questionnaires. 
 
Thank you very much for reading this letter.   If you would like to know more about the 
research you are very welcome to read the ‘Information Sheet’. If you decide you would like to 
meet up we would also go through this information together then, to check everything is clear 
before you decide whether to take part. 
If you are interested and would be happy for me to phone you, I’d be very grateful if you could 
let your Care Coordinator know. 
Thanks very much for your time. 
Best Wishes, 
                             Miss Emma Stephens   Dr Lorna Hogg 
                             Trainee Clinical Psychologist  Clinical Psychologist 
                             University of Bath    University of Bath 
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APPENDIX B- Participant Information Sheet 
 
Factors associated with Engagement in First Episode Psychosis. 
You are being invited to take part in a research study. Before you decide if you want to 
take part, it is important for you to understand why the research is being done and what 
it will involve. Please ask if there is anything that is not clear or you would like more 
information about. You can talk to your Care Coordinator, family or friends and take 
time to decide whether or not you wish to take part. 
What is the purpose of the study? 
We are inviting you to take part in a study looking at factors such as recovery style 
(which is the way people adapt to their experience of psychosis e.g., push it to the back 
of their minds or explore experiences), attachment style (how someone relates to others) 
and how they tend to feel about themselves in difficult times (e.g. self critical or kind 
and understanding). This project is being completed as part of a doctorate in clinical 
psychology. 
Why have I been invited to take part? 
We are approaching all patients who have been referred to a local Early Intervention 
service within the past year to ask if they want to help us explore what makes engaging 
with these services easier or harder. Your Care Coordinator has agreed for us to 
approach you. 
Do I have to take part? 
No, taking part is voluntary. If you would prefer not to take part you do not have to give 
a reason. Staff involved in your care will not be upset and your treatment will not be 
affected. If you take part but later change your mind, you can withdraw at any time from 
the study without affecting your care.  
What will happen to me if I take part? 
If you decide to take part, you will be asked to meet with a researcher to complete some 
questionnaires about your experiences of mental health problems, and your viewpoints 
on recovery and relationships. The interview will take around one hour in total. We will 
try to make appointments at times which suit you. Interviews will normally take place in 
your own home but may be able to be arranged in a room in at the Early Intervention 
Service if you prefer.  
Expenses and Payments 
You will receive £5 in cash for taking part in the research study. 
 
What are the possible disadvantages and risks of taking part? 
The questions we ask are about things that you may have been asked before (e.g., about 
your mental health). It is possible that these questions might cause some distress. You 
do not have to answer any questions you do not want to and can stop the interview at 
any time. If you do feel distressed as a result of the interview you can contact your Care 
Coordinator on 0117 919 2371 or the researcher at the University via 
es555@bath.ac.uk. If you are feeling very distressed during out of office hours, you can 
contact out of hours services such as the Samaritans 08457 90 90 90 or Crisis Team on 
0300 555 0334. 
What are the possible benefits? 
We hope the information we get from this study will help services better meet the needs 
of people experiencing psychosis, and ultimately lead to better outcomes for patients. 
You will receive £5 reimbursement for your time. 
What happens when the research study stops? 
The study will be written up as partial fulfilment of a Doctorate in Clinical Psychology 
at the University of Bath. All personal contact details (address, phone number etc) will 
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be destroyed as soon as they are no longer needed (after interview has taken place). 
After the study is completed, the anonymous questionnaire data will be kept securely 
for 10 years after publication of the study, in accordance with the University of Bath 
policy on storage of research data. Consent forms from the study will also be kept 
securely for this time, after which all study data will be destroyed. 
Will my taking part in the study be kept confidential? 
Yes. All information which is collected about you during the course of the research will 
be kept strictly confidential, and none of the questionnaires will not have your name or 
address so that you cannot be recognised. We will follow ethical and legal practice and 
we will conform to the Data Protection Act of 1998 with respect to data collection, 
storage and destruction. 
As you are under the care of a mental health NHS Trust, a copy of your consent form 
will be copied into your usual medical notes. Your Care Coordinator has seen a copy of 
this information sheet. We have a responsibility to inform your Care Coordinator if you 
tell us information that suggests you or someone else might be harmed. 
What will happen to the results of the research study? 
The study will be written up as partial fulfilment of a Doctorate in Clinical Psychology 
at the University of Bath and a paper will be submitted to a relevant scientific journal. 
An overview of the results will be sent to all services who took part to be distributed if 
requested. 
What if there is a problem? 
If you have a concern about any aspect of this study, you should contact the researchers 
Emma Stephens or Dr Lorna Hogg who will do their best to answer your questions 
(Emma Stephens- es555@bath.ac.uk  Dr Lorna Hogg- l.i.hogg@bath.ac.uk). If you 
remain unhappy and wish to complain formally, you can do this through the NHS 
Complaints Procedure (Details can be obtained from your Primary Care/NHSTrust) or 
you can contact the Research Governance Sponsor of this study, University of Bath. 
Please write to: Research Governance, University of Bath, Claverton, Bath, BA3 7AY. 
Who is organising and funding the research? 
Money for participants and for the researcher’s travel and photocopying expenses will 
come from a research budget available via the Department of Clinical Psychology 
within the University of Bath. 
Who has reviewed the study? 
The study has been reviewed by an NHS Research Ethics Committee. The study 
protocol was also reviewed and approved by a research sub-committee constituting 
senior staff from the Department of Clinical Psychology within the University of Bath. 
 
Thank you very much for considering taking part in our research. Please discuss 
this information with your family, friends or mental health team if you wish before 
deciding.Please let your Care Coordinator know if you are happy to be contacted 
by the researcher on the phone so that they can answer any questions and book in 
















Thank You  




 Your answers will be anonymous 
 Take a break at any time! 
 You can decide not to answer 
questions you don’t want to 
 If you prefer I can read the questions 





HOW I TYPICALLY ACT TOWARDS MYSELF IN DIFFICULT TIMES 
 
Please read each statement carefully before answering. To the left of each item, 
indicate how often you behave in the stated manner, using the following scale: 
 
Almost             Almost 
never               always 
    1             2         3    4    5 
 
_____1. When I fail at something important to me I become consumed by 
feelings of inadequacy. 
 
_____2. I try to be understanding and patient towards those aspects of my 
              personality I don’t like. 
 
_____3. When something painful happens I try to take a balanced view of the 
              situation. 
 
_____4. When I’m feeling down, I tend to feel like most other people are 
probably happier than I am. 
 
_____5. I try to see my failings as part of the human condition. 
 
_____6. When I’m going through a very hard time, I give myself the caring and 
tenderness I need. 
 
_____7. When something upsets me I try to keep my emotions in balance. 
 
_____8. When I fail at something that’s important to me, I tend to feel alone in 
my failure 
 
_____9. When I’m feeling down I tend to obsess and fixate on everything that’s 
wrong. 
 
_____10. When I feel inadequate in some way, I try to remind myself that 
feelings of inadequacy are shared by most people. 
 
_____11. I’m disapproving and judgmental about my own flaws and 
inadequacies. 
 













HOW I FEEL OTHERS SEE ME (OAS) 
 
We are interested in how people think others see them. Below is a list of statements 
describing feelings or experiences about how you may feel other people see you. 
 
Read each statement carefully and circle the number to the right of the item that indicates 
the frequency with which you find yourself feeling or experiencing what is described in the 
statement. Use the scale below. 
0 = NEVER 1 = SELDOM 2 = SOMETIME 3 = FREQUENTLY 4 = ALMOST 
ALWAYS  
 
1. I feel other people see me as not good enough.    0    1    2    3    4           
 
2. I think that other people look down on me    0    1    2    3    4 
 
3. Other people put me down a lot      0    1    2    3    4 
 
4. I feel insecure about others opinions of me    0    1    2    3    4 
 
5. Other people see me as not measuring up to them   0    1    2    3    4 
 
6. Other people see me as small and insignificant    0    1    2    3    4 
 
7. Other people see me as somehow defective as a person   0    1    2    3    4 
 
8. People see me as unimportant compared to others   0    1    2    3    4 
 
9. Other people look for my faults      0    1    2    3    4 
 
10. People see me as striving for perfection but being unable to 0    1    2    3    4 
      reach my own standards  
 
11. I think others are able to see my defects     0    1    2    3    4 
 
12. Others are critical or punishing when I make a mistake   0    1    2    3    4 
 
13. People distance themselves from me when I make mistakes  0    1    2    3    4 
 
14. Other people always remember my mistakes    0    1    2    3    4 
 
15. Others see me as fragile       0    1    2    3    4 
 
16. Others see me as empty and unfulfilled     0    1    2    3    4 
 
17. Others think there is something missing in me    0    1    2    3    4 
 
18. Other people think I have lost control over my body                   0    1    2    3    4 
      and feelings  





The Recovery Style Questionnaire (RSQ) 
Written below are a list of statements about your illness. Please read them 




HOW I RELATE TO OTHERS 
We all differ in how we relate to other people.  This questionnaire lists different 
thoughts, feelings and ways of behaving in relationships with others. 
PART A 
Thinking generally about how you relate to other key people in your life, please 
use a tick to show how much each statement is like you.  Key people could 
include family members, friends, partner or mental health workers. 
There are no right or wrong answers 
 Not at 
all 




1. I prefer not to let other 
people know my ‘true’ 
thoughts and feelings.  
(..) (..) (..) (..) 
2. I find it easy to depend on 
other people for support with 
problems or difficult 
situations.  
(..) (..) (..) (..) 
 
3. I tend to get upset, anxious 
or angry if other people are 
not there when I need them. 
(..) (..) (..) (..) 
 
4. I usually discuss my 
problems and concerns with 
other people.  
(..) (..) (..) (..) 
5. I worry that key people in 
my life won’t be around in the 
future. 
(..) (..) (..) (..) 
6. I ask other people to 
reassure me that they care 
about me.  
(..) (..) (..) (..) 
7. If other people disapprove 
of something I do, I get very 
upset. 
(..) (..) (..) (..) 
8. I find it difficult to accept 
help from other people when 
I have problems or 
difficulties. 
(..) (..) (..) (..) 
9. It helps to turn to other 
people when I’m stressed. 
(..) (..) (..) (..) 
10. I worry that if other 
people get to know me 
better, they won’t like me. 
(..) (..) (..) (..) 
 







 Not at 
all 




11. When I’m feeling 
stressed, I prefer being on my 
own to being in the company 
of other people.  
(..) (..) (..) (..) 
12. I worry a lot about my 
relationships with other 
people.  
(..) (..) (..) (..) 
13. I try to cope with stressful 
situations on my own.  
(..) (..) (..) (..) 
14. I worry that if I displease 
other people, they won’t want 
to know me anymore.  
(..) (..) (..) (..) 
15. I worry about having to 
cope with problems and 
difficult situations on my own. 
(..) (..) (..) (..) 
 
16. I feel uncomfortable when 
other people want to get to 
know me better. 










(E.g. relationship with mother, father, sister, brother, husband, wife, friend, 
romantic partner, mental health workers etc) 
 
Thank You…  
I really appreciate your help. We hope that this research will help us 
understand better what can affect people’s recovery from difficult 













APPENDIX D- ETHICAL APPROVAL & R&D CORRESPONDANCE 
 
 24 April 2015  
Miss Emma-Jane Kirsten Stephens  
Trainee Clinical Psychologist  
Taunton NHS  
Department of Clinical Psychology  
University of Bath  





 Dear Miss Stephens  
 
Study title:  
 
 
The influence of self compassion and shame on 
engagement with services and recovery style in first 
episode psychosis.  
REC reference:  15/NW/0311  
Protocol number:  n/a  
IRAS project ID:  162293  
 
 
 Thank you for your submission responding to the Proportionate Review Sub-
Committee’s request for changes to the documentation for the above study.  
 
The revised documentation has been reviewed and approved by the sub-committee.  
We plan to publish your research summary wording for the above study on the HRA 
website, together with your contact details. Publication will be no earlier than three 
months from the date of this favourable opinion letter. The expectation is that this 
information will be published for all studies that receive an ethical opinion but should 
you wish to provide a substitute contact point, wish to make a request to defer, or 
require further information, please contact the REC Manager Rachel 
Katzenellenbogen, nrescommittee.northwest-haydock@nhs.net. Under very limited 
circumstances (e.g. for student research which has received an unfavourable opinion), 
it may be possible to grant an exemption to the publication of the study.  
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for 
the above research on the basis described in the application form, protocol and 
supporting documentation as revised.  
 
Conditions of the favourable opinion  
The favourable opinion is subject to the following conditions being met prior to the start 
of the study.  
Management permission or approval must be obtained from each host organisation 
prior to the start of the study at the site concerned.  
Management permission (“R&D approval”) should be sought from all NHS 
organisations involved in the study in accordance with NHS research governance 
arrangements.  
Guidance on applying for NHS permission for research is available in the Integrated 
Research Application System or at http://www.rdforum.nhs.uk.  
Where a NHS organisation’s role in the study is limited to identifying and referring 
potential participants to research sites (“participant identification centre”), guidance 
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should be sought from the R&D office on the information it requires to give permission 
for this activity.  
For non-NHS sites, site management permission should be obtained in accordance 
with the procedures of the relevant host organisation.  
Sponsors are not required to notify the Committee of approvals from host 
organisations. 
 
Registration of Clinical Trials  
All clinical trials (defined as the first four categories on the IRAS filter page) must be 
registered on a publically accessible database. This should be before the first 
participant is recruited but no later than 6 weeks after recruitment of the first participant.  
There is no requirement to separately notify the REC but you should do so at the 
earliest opportunity e.g. when submitting an amendment. We will audit the registration 
details as part of the annual progress reporting process.  
To ensure transparency in research, we strongly recommend that all research is 
registered but for non-clinical trials this is not currently mandatory.  
If a sponsor wishes to request a deferral for study registration within the required 
timeframe, they should contact hra.studyregistration@nhs.net. The expectation is that 
all clinical trials will be registered, however, in exceptional circumstances non 
registration may be permissible with prior agreement from NRES. Guidance on where 
to register is provided on the HRA website.  
 
It is the responsibility of the sponsor to ensure that all the conditions are 
complied with before the start of the study or its initiation at a particular site (as 
applicable).  
 
Ethical review of research sites  
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the 
start of the study (see “Conditions of the favourable opinion” above).  
 
Approved documents  
The documents reviewed and approved by the Committee are: 
 
Document  Version  Date  
Covering letter on headed paper [Cover Letter]  1  12 March 2015  
Evidence of Sponsor insurance or indemnity (non NHS 
Sponsors only) [Indemnity Confirmation]  
1  25 March 2015  
Letter from sponsor [Sponsorship Approval]  1  25 March 2015  
Letters of invitation to participant [Invite letter]  1  25 March 2015  
Other [Care Coordinators Questionnaire Pack]  1  25 March 2015  
Other [liability certificate]  1  25 March 2015  
Other [letter academic approval]  1  25 March 2015  
Other [Debrief sheet]  1  25 March 2015  
Other [Field Supervisor CV]  1  25 March 2015  
Other [Demographic Sheet]  1  25 March 2015  
Other [Site information]  26 March 2015  
Other [Data clarification]  1  14 April 2015  
Participant consent form [Patient] 1  25 March 2015  
Participant consent form [Care Coordinator]  26 March 2015  
Participant consent form [Consent Form]  2  13 April 2015  
Participant information sheet (PIS) [Patient]  1  25 March 2015  
Participant information sheet (PIS) [Care Coordinator]  26 March 2015  
Participant information sheet (PIS) [Participant Info sheet]  2  25 March 2015  
REC Application Form [REC_Form_26032015]  26 March 2015  
Research protocol or project proposal [Protocol]  1  25 March 2015  
Summary CV for Chief Investigator (CI) [Emma Stephens 
CV]  
1  25 March 2015  
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Summary CV for supervisor (student research) [Lorna 
Hogg CV]  
1  25 March 2015  
Summary, synopsis or diagram (flowchart) of protocol in 
non technical language [Lay Summary]  
1  25 March 2015  
Validated questionnaire [Questionnaire pack]  1  25 March 2015  
 
Statement of compliance  
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.  
 
After ethical review  
Reporting requirements  
The attached document “After ethical review – guidance for researchers” gives detailed 








The HRA website also provides guidance on these topics, which is updated in the light 
of changes in reporting requirements or procedures.  
 
Feedback  
You are invited to give your view of the service that you have received from the 
National Research Ethics Service and the application procedure. If you wish to make 
your views known please use the feedback form available on the HRA website: 
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance  
We are pleased to welcome researchers and R & D staff at our NRES committee 
members’ training days – see details at http://www.hra.nhs.uk/hra-training/  
 
15/NW/0311 Please quote this number on all correspondence  
 
With the Committee’s best wishes for the success of this project.  
 
Yours sincerely  
 
Dr Tim S Sprosen  
Chair  
 
Email: nrescommittee.northwest-haydock@nhs.net  
 
Copy to:  
 
Ms Lorna Hogg, University of Bath  














29th June 2015 
 
Our R&D ref: 15/017/2GT 
 
Department of Clinical Psychology 







RE:  The influence of self-compassion and shame on engagement with services 
in first episode psychosis.  
 
Participating Organisation: 2gether NHS Foundation Trust 
 
This letter should be presented to each participating organisation before you 
commence your research at that site. The participating organisation is 2gether 
NHS Foundation Trust. 
 
In accepting this letter, each participating organisation confirms your right of 
access to conduct research through their organisation for the purpose and on 
the terms and conditions set out below. This right of access commences on 29th 
June 2015 and ends on completion of all research activity for the named study, 
unless terminated earlier in accordance with the clauses below.  
 
You have a right of access to conduct such research as confirmed in writing in 
the letter of permission for research from 2gether NHS Foundation Trust. Please 
note that you cannot start the research until the Principal Investigator for the 
research project has received a letter from us giving confirmation from the 
individual organisation(s) of their agreement to conduct the research. 
 
The information supplied about your role in research at the organisation(s) has 
been reviewed and you do not require an honorary research contract with the 
organisation(s). We are satisfied that such pre-engagement checks as we 
consider necessary have been carried out. Evidence of checks should be 
available on request to the organisation(s).  
 
You are considered to be a legal visitor to the organisations premises. You are 
not entitled to any form of payment or access to other benefits provided by the 
organisation(s) or this organisation to employees and this letter does not give rise 
to any other relationship between you and the organisation(s), in particular that 
of an employee.  
 
While undertaking research through the organisation(s) you will remain 
accountable to your substantive employer, the University of Bristol, but you are 
required to follow the reasonable instructions of the organisation(s) or those 
instructions given on their behalf in relation to the terms of this right of access. 
 
Where any third party claim is made, whether or not legal proceedings are 
issued, arising out of or in connection with your right of access, you are required 
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to co-operate fully with any investigation by the organisation(s) in connection 
with any such claim and to give all such assistance as may reasonably be 
required regarding the conduct of any legal proceedings. 
 
You must act in accordance with the organisations policies and procedures, 
which are available to you upon request, and the Research Governance 
Framework.  
 
You are required to co-operate with the organisation(s) in discharging its/their 
duties under the Health and Safety at Work etc Act 1974 and other health and 
safety legislation and to take reasonable care for the health and safety of 
yourself and others while on the organisations premises. You must observe the 
same standards of care and propriety in dealing with patients, staff, visitors, 
equipment and premises as is expected of any other contract holder and you 
must act appropriately, responsibly and professionally at all times.  
 
If you have a physical or mental health condition or disability which may affect 
your research role and which might require special adjustments to your role, if 
you have not already done so, you must notify your employer and each 
organisation prior to commencing your research role at that organisation.  
 
You are required to ensure that all information regarding patients or staff remains 
secure and strictly confidential at all times. You must ensure that you understand 
and comply with the requirements of the NHS Confidentiality Code of Practice 
and the Data Protection Act 1998. Furthermore you should be aware that under 
the Act, unauthorised disclosure of information is an offence and such disclosures 
may lead to prosecution.  
 
You should ensure that, where you are issued with an identity or security card, a 
bleep number, email or library account, keys or protective clothing, these are 
returned upon termination of this arrangement. Please also ensure that while on 
the organisations premises you wear your ID badge at all times, or are able to 
prove your identity if challenged. Please note that the organisation(s) do not 
accept responsibility for damage to or loss of personal property. 
 
This organisation may revoke this letter and any organisation(s) may terminate 
your right to attend at any time either by giving seven days’ written notice to you 
or immediately without any notice if you are in breach of any of the terms or 
conditions described in this letter or if you commit any act that we reasonably 
consider to amount to serious misconduct or to be disruptive and/or prejudicial 
to the interests and/or business of the organisation(s) or if you are convicted of 
any criminal offence.   You must not undertake regulated activity if you are 
barred from such work. If you are barred from working with adults or children this 
letter of access is immediately terminated.  
 
Your employer will immediately withdraw you from undertaking this or any other 
regulated activity and you MUST stop undertaking any regulated activity 
immediately. 
 
Your substantive employer is responsible for your conduct during this research 
project and may in the circumstances described above instigate disciplinary 




No organisation will indemnify you against any liability incurred as a result of any 
breach of confidentiality or breach of the Data Protection Act 1998. Any breach 
of the Data Protection Act 1998 may result in legal action against you and/or 
your substantive employer. 
 
If your current role or involvement in research changes, or any of the information 
provided in your Research Passport changes, you must inform your employer 
through their normal procedures. You must also inform your nominated manager 









Senior Research Governance Manager 
 
Gloucestershire R&D Consortium) 
(Gloucestershire Hospitals NHS Foundation Trust/2gether NHS Foundation 



























 Our Reference: 887AWP  
Emma-Jane Stephens  
Department of Clinical Psychology  
University of Bath  
Claverton Down  
Bath  
BA2 7AY  
8th July 2015  
  
  
Dear Emma,  
 
Title of study: The influence of self-compassion and shame on engagement 
with services and recovery style in first episode psychosis.  
 
Approval date: 08 July 2015  
End date: 01 April 2016  
 
Thank you very much for applying to undertake your research in AWP, we pride 
ourselves on a straight forward and rapid process for research governance and project 
management.  
 
We are pleased to advise that we have been able to grant R&D Permission at Avon 
and Wiltshire Mental Health Partnership NHS Trust (“the Trust”).  
We also require you to document any study activity on RiO for the relevant patient 
records. Please refer to the attached document for guidance.  
 
We now use EDGE (a Clinical Management System) to manage our research studies. 
As part of your approval you will be issued with an account and guide and will be 
expected to upload AWP recruitment figures regularly. This is a requirement from 01 
April 2014 for all research recruiting in the Trust. Failure to comply with this will result in 
your research being suspended, so please make sure you complete this on a monthly 
basis.  
 
The R&D Permission in the Trust is valid until 01 April 2016. If you require any 
extension to this in the future please contact us to arrange. The documentation listed 
below has been received and all the relevant governance checks have now been 
completed. I am therefore happy to provide R&D Permission for the above study 
across all locations within the Trust parameters. 
 
You are reminded that you must report any adverse event or incident whether or not 
you feel it is serious, quoting the study reference number. This requirement is in 
addition to informing the Chairman of the relevant Research Ethics Committee. You are 
also required to submit to the Research and Development Operations Manager 
(Hannah Antoniades) a final outcome report on completion of your study, and if 
necessary to provide interim annual reports on progress. Should publications arise, 
please also send copies to Hannah Antoniades for inclusion in the study’s site file.  
 
You must also abide by the research and information governance requirements for any 
research conducted within the NHS:  
 
ne with the Research Governance Framework which 
details the responsibilities of everyone involved in research.  
date Data Protection Registration with the Information Commissioners Office. Where 
staff are employed, this includes having robust contracts of employment in place and 
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ensuring that staff are made aware of their obligations through training and similar 
initiatives.  
ith the requirements of the NHS 




storage, transfer and disposal of information both personal and sensitive, or corporate 
sensitive information. Any information security breach must be reported immediately to 
the Trust.  
ust not be further 
disclosed without the explicit consent of the Trust unless there is an override required 
by law. Where disclosure is required under the Freedom of Information Act 2000, the 
Trust will assist you in processing the request.  
 
Please note that, as a public authority, the Trust is obligated to comply with the 
provisions of the Freedom of Information Act 2000, including the potential disclosure of 
information held by the Trust in connection with this study. Where a request for 
potential disclosure of personal, corporate sensitive, or contract information is made 
under the Freedom of Information Act 2000, due regard shall be made to any duty of 
confidentiality or commercial interest.  
 
Yours sincerely  
 
Hannah Antoniades  
Research & Development Operations Manager  
Avon and Wiltshire Mental Health Partnership NHS Trust  
 
CC:  
Lorna Hogg (Bath University Academic Supervisor)  




















APPENDIX E- Amendment Correspondance 
 
 Our Ref: AWP 887  
Miss Emma Stephens  
Trainee Clinical Psychologist  
Department of Clinical Psychology  
University of Bath  
Claverton Down  
Bath  
BA2 7AY  
27 November 2015  
Hannah Antoniades  
Research and Development  
Avon & Wiltshire Mental Health Partnership NHS 
Trust  
Fromeside  
Blackberry Hill Hospital  
Manor Road  
Fishponds  
Bristol  
BS16 1EG  
0117 378 4267  
hannah.antoniades@awp.nhs.uk  
 
Dear Emma,  
 
Title of study: The influence of self-compassion and shame on engagement with 
services and recovery style in first episode psychosis.  
 
REC ref: 15/NW/0311  
Amendment no: 01  
Approval date: 27 November 2015  
End date: 01 April 2016  
 
I am pleased to advise you that I have reviewed the amended documents (listed below) 
for the above study, and am happy for Avon and Wiltshire Mental Health Partnership 
NHS Trust to continue to be a site for this project.  
 
I can confirm that we have received the Research Ethics Committee 





Participant information sheet (PIS)  
 
 
 Yours sincerely,  
Hannah Antoniades  
Deputy Director of Research & Development  
Avon and Wiltshire Mental Health Partnership NHS Trust  
CC:  
Lorna Hogg (Bath University Academic Supervisor)  
















Miss Emma-Jane Kirsten Stephens 
Trainee Clinical Psychologist 
Taunton NHS 
Department of Clinical Psychology 
University of Bath 
Claverton Down 
Bath 





The influence of self-compassion and shame on engagement with services and 
recovery style in first episode psychosis. 
 
REC reference: 15/NW/0311  Protocol number:n/a 
Amendment number:2  Amendment date: 20 January 2016 
IRAS project ID: 162293 
 
Summary: 
Approval is sought for changes made to protocol to include researchers to attend groups 
run by the Early Intervention service (e.g. Recovery groups, Occupational therapy 
groups) to briefly inform members about the research and distribute information sheets. 




The members of the Committee taking part in the review gave a favourable ethical 




The documents reviewed and approved at the meeting were: 
 
Membership of the Committee  
The members of the Committee who took part in the review are listed on the attached 
sheet.  
 
R&D approval  
All investigators and research collaborators in the NHS should notify the R&D office 
for the relevant NHS care organisation of this amendment and check whether it affects 
R&D approval of the research.  
 
Statement of compliance  
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.  
We are pleased to welcome researchers and R & D staff at our NRES committee 
members’ training days – see details at http://www.hra.nhs.uk/hra-training/  




Yours sincerely  
 
Ewan Waters  
REC Assistant  
PP: Dr Tim S Sprosen  
Chair  
E-mail: nrescommittee.northwest-













































 Our Ref: AWP 887  
Miss Emma Stephens  
Trainee Clinical Psychologist  
Department of Clinical Psychology  
University of Bath  
Claverton Down  
Bath  
BA2 7AY  
01 March 2016  
Dr Julian Walker  
Research and Development  
Avon & Wiltshire Mental Health Partnership NHS 
Trust  
Fromeside  
Blackberry Hill Hospital  
Manor Road  
Fishponds  
Bristol  
BS16 1EG  




Dear Emma,  
 
Title of study: The influence of self-compassion and shame on engagement with 
services and recovery style in first episode psychosis.  
 
REC ref: 15/NW/0311  
Amendment no: Sub Amend 02  
Approval date: 01 March 2016  
End date: 01 April 2016  
 
I am pleased to advise you that I have reviewed the amended documents (listed below) 
for the above study, and am happy for Avon and Wiltshire Mental Health Partnership 
NHS Trust to continue to be a site for this project.  
 
I can confirm that we have received the Research Ethics Committee favourable opinion 
dated 20 January 2016 with the amendment approval request. 
 
Yours sincerely,  
 
Director of Research & Development  
Avon and Wiltshire Mental Health Partnership NHS Trust  
 
CC:  
Lorna Hogg (Bath University Academic Supervisor)  






















OUR R&D REF: 15/017/2gt 
  
Miss Emma-Jane Stephens 
Trainee Clinical Psychologist 
Department of Clinical Psychology 




 Dear Miss Stephens, 
  
Study Title: The influence of self-compassion and shame on 
engagement with services and recovery style in first episode 
psychosis. 
REC Ref. NO 15/NW/0311 
IRAS Ref. NO 162293 
Amendment Ref. NO Substantial Amendment 1 12.11.2015 and 
Substantial Amendment 2 20.01 2016 
  
Thank you for notifying me about the above study amendments for review by the 
Gloucestershire Research Support Service on behalf of 2gether NHS Foundation Trust. 
  
These amendments have been reviewed and approved by the Senior Research 
Governance Manager, Mark Walker. The trust is able to support this amendment to the 
above study on the basis of the information provided and as per the 
REC Amendment Favourable Ethical Opinion Letters, dated 26th November 2015 
(Amendment 1) and 11th February 2016 (Amendment 2). 




         Notice of Substantial Amendment (non-CTIMP)1 12 November 2015 




         Notice of Substantial Amendment (non-CTIMP) 2 20 January 2016 
         Research protocol or project proposal 2 dated 22 January 2016 
  
 Please don’t hesitate t contact me if you have any queries. 
 We continue to wish you well with your study. 
  
 Kind Regards 
Nigel 
Nigel Johnson| Research Governance Support Officer| Gloucestershire Hospitals NHS 
Foundation Trust/2gether NHS Foundation Trust/Gloucestershire Care 
Services/Gloucestershire Clinical Commissioning Group 
Gloucestershire Research Support Service | Leadon House | Great Western Road | 
Gloucestershire Royal Hospital  |Gloucester| GL1 3NN  




























Search: Index Terms: {Anxiety} AND 
Index Terms: {Parkinson's Disease} 
Result(s): 97 
Deleted due to not being journal articles 
(chapters, dissertations, letters, book 
reviews etc): 16  
Final Total: 81 
 
PubMed  
Search: MeSH Terms Parkinson 
Disease & Anxiety (both non -
exploded), Filtered by HUMAN. 
Result: 88  
Those found already in PsychINFO: 25 
Final Total: 63 
 
Total PsychInfo & Pubmed: 142 
Deletions following review of Abstracts: 
Rat/mice studies: 4 
Non relevant: 14 (about loss of smell, libido, about schizophrenia medication, tremor not PD, 
about caregiver stress, about depression only, about recognising facial expressions, gene study, 
falls, psychosis) 
Article in foreign Language: 8 
Single case study: 6 
Non article (e.g. comment/letter): 7 
Final Total: 104 
 
Brief review to categorise paper themes: 
Disease factors: 26 







After removing the non-relevant papers (e.g. solely 
neurological/pharmacological, scales), the remaining 66 papers were reviewed 
in more detail and a final total of 30 papers were identified as relevant to the 




APPENDIX G- OCD-UK Questionnaire Pack 
Pre Questionnaire 1- Experience & Expectations of the Day 










Please rate how experienced you currently feel you are at working with people with 
OCD: 
Very                   Quite                  Not Very      Not at all   
Experienced      Experienced       Experienced      Experienced 
 
    
 
Please rate how confident you currently feel about: 
Very    Quite        Not Very     Not at all 
Confident       Confident          Confident    Confident 
 




What the evidence-based 
treatments for OCD are? 
 
Assessing risk in OCD e.g. 
thoughts of harming others 
 
Having some insight into 
what it feels like to 
experience OCD? 
 
Involving family/carers in 
the treatment of OCD? 
 
 











CBT Therapist/High Therapist   
Trainee CBT Therapist  
Trainee Clinical/Counselling Psychologist  
Clinical/Counselling Psychologist  
Counsellor  
PWP/Low Intensity Worker  
Mental Health Nurse  
Other...Please specify:  
    
    
    
    
    
    
How did you hear about the conference? 
 
 
What are your expectations/hopes for the day? 
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Pre-Questionnaire 2- Therapy Relevant Beliefs  
 
People develop beliefs about a condition from past experience, the media, and other 
influences. Please complete the following anonymous questionnaire about you beliefs 
about OCD. Please rate each item on a scale from 0 to 100, where 0 indicates “Do not 
agree at all” and 100 indicates “Completely agree”. 
Question Rating 0 to 100: 
 
1. OCD is caused by a chemical imbalance in the brain.  
2. OCD is a psychological problem  
3. I believe that obsessional problems can be overcome.  
4. I am certain that only psychological therapy can help people to beat 
OCD. 
 
5. I am certain that only medication therapy can help people to beat 
OCD. 
 
6. There’s something wrong with the personality of obsessional people 
which means they’re unlikely to overcome their problems. 
 
7. People with OCD have something physically wrong with them.  
8. I have dispensed good therapy for the OCD in the past.  
9. I have dispensed the wrong therapy for the OCD in the past.  
10. I have not given the obsessional patients I have seen enough 
therapy. 
 
11. OCD is a chronic condition which can be managed but not cured.  
12. I am optimistic about people’s abilities to overcome the OCD.  
13. In my experience, most therapists don’t understand OCD.  
14. My patients have not made as much progress in beating OCD as I 
would have liked them to, because of faults of their own. 
 
15. My patients have not made as much progress in beating OCD as I 
would have liked them to, because of my therapy not being good 
enough. 
 
16. My patients have not made as much progress in beating OCD as I 
would have liked them to, because OCD is a difficult problem to 
beat. 
 
17. My patients have not made as much progress in beating OCD as I 
would have liked them to, because of other life difficulties which 
they have. 
 
18. My patients have not made as much progress in beating OCD as I 
would have liked them to, because of bad things that happened to 
them when they were younger. 
 
19. The therapy I have done in the past has not focussed sufficiently on 
the obsessional problem. 
 
20. Over time I have become more and more pessimistic about the 
chances of treating OCD successfully. 
 









Post Questionnaire 1- Feedback 
Please rate the overall content of the day on the following: 
  Very Good  Quite Good   Not Very Good   Not at all Good 
Interest of topics 
 






Positive impact on 
your feelings about 
OCD treatment 
 
Please rate how confident you feel about: 
         Very   Quite    Not Very     Not at all 
      Confident          Confident Confident    Confident 
What the evidence 
based treatments for 
OCD are? 
 




Assessing risk in OCD 
e.g. thoughts of 
harming others 
 
Having some insight 




in the treatment of 
OCD? 
 
How well did the day meet your expectations?  












    
    
    
    
    
    
    
    
    
What would you like to see in future Professionals’ Conferences? Please give 
details:          
 
 






Post Questionnaire 2- Therapy Relevant Beliefs  
People develop beliefs about a condition from past experience, the media, and other 
influences. Please complete the following anonymous questionnaire about you beliefs 
about OCD.  Please rate each item on a scale from 0 to 100, where 0 indicates “Do not 
agree at all” and 100 indicates “Completely agree”. 
 
Question Rating 0 to 100: 
 
1. OCD is caused by a chemical imbalance in the brain.  
2. OCD is a psychological problem  
3. I believe that obsessional problems can be overcome.  
4. I am certain that only psychological therapy can help people to beat 
OCD. 
 
5. I am certain that only medication therapy can help people to beat 
OCD. 
 
6. There’s something wrong with the personality of obsessional people 
which means they’re unlikely to overcome their problems. 
 
7. People with OCD have something physically wrong with them.  
8. I have dispensed good therapy for the OCD in the past.  
9. I have dispensed the wrong therapy for the OCD in the past.  
10. I have not given the obsessional patients I have seen enough 
therapy. 
 
11. OCD is a chronic condition which can be managed but not cured.  
12. I am optimistic about people’s abilities to overcome the OCD.  
13. In my experience, most therapists don’t understand OCD.  
14. My patients have not made as much progress in beating OCD as I 
would have liked them to, because of faults of their own. 
 
15. My patients have not made as much progress in beating OCD as I 
would have liked them to, because of my therapy not being good 
enough. 
 
16. My patients have not made as much progress in beating OCD as I 
would have liked them to, because OCD is a difficult problem to 
beat. 
 
17. My patients have not made as much progress in beating OCD as I 
would have liked them to, because of other life difficulties which 
they have. 
 
18. My patients have not made as much progress in beating OCD as I 
would have liked them to, because of bad things that happened to 
them when they were younger. 
 
19. The therapy I have done in the past has not focussed sufficiently on 
the obsessional problem. 
 
20. Over time I have become more and more pessimistic about the 
chances of treating OCD successfully. 
 









APPENDIX H- Literature Review Journal Instructions for Authors 
PREPARATION OF MANUSCRIPTS 
Research Reports 
Organization and style of presentation 
Manuscripts must be written in English. Authors whose native language is not English are recommended 
to seek the advice of a native English speaker, if possible, before submitting their manuscripts.  
Manuscripts should be double spaced throughout with wide margins (2.5cm or 1in), including the abstract 
and references. Every page of the manuscript, including the title page, references, tables, etc., should 
include a page number centered at the bottom. 
Manuscripts should be organized in the following order with headings and subheadings typed on a 
separate line, without indentation.  
Title Page 
1. Title (should be clear, descriptive and concise). 
2. Full name(s) of author(s). 
3. Full affiliation(s). Delineate affiliations with lowercase letters. 
4. Present address of author(s), if different from affiliation. 
5. Running title (45 characters or less, including spaces). 
6. Complete correspondence address, including telephone number, fax number and e-mail address. 
Leave the author information blank if double-blind peer review is wished for, but do include the 
information in the submission letter to the editor. 
Abstract and Keywords 
The abstract for research papers should follow the “structured abstract” format: 
BACKGROUND: OBJECTIVE: METHODS: RESULTS: CONCLUSIONS: 
The abstract should try to be no longer than 250 words.  
For other papers such as Reviews, the abstract should be clear, descriptive, and self-explanatory, and no 
longer than 250 words. 
Include a list of 4-10 keywords. These keywords should be terms from the MeSH database. 
Introduction 
Materials and Methods 
There is no word limit to the materials and methods section, as the journal’s policy is that methodological 
rigour and reproducibility is of great importance. 
Results 
Discussion 
Acknowledgments including sources of support 
Conflict of Interest 
If there is no conflict of interest to declare, do still include this section and insert “The authors have no 
conflict of interest to report” 
Reviews 
Reviews should be authoritative and topical and provide comprehensive and balanced coverage of a 
timely and/or controversial issue. Reviews should be prepared as detailed above for a Research Report 
omitting Introduction through Discussion, and include a Conclusion. When submitting a Review, clearly 





APPENDIX I- Service Improvement Project Journal Instructions for Authors 
 
Style Guide  
 
• Title page. The title should phrase concisely the major issues. Author(s) to be given 
with departmental affiliations and addresses, grouped appropriately. A running head of 
no more than 40 characters should be indicated.  
 
• Abstract. The abstract should include up to six key words that could be used to 
describe the article. This should summarize the article in no more than 250 words, 
references should not to be included in the abstract.  
 
• All articles must include a set of 3-5 learning objectives that will be achieved through 
reading the paper. At the end of each paper a summary of the main points from the 
paper must be included with suggestions for follow-up reading. This stipulation is in 
keeping with the practitioner and professional development aims of the journal.  
 
• Text. This should begin with an introduction, succinctly introducing the point of the 
paper to those interested in the general area of the journal. Attention should be paid to 
the Editorial Statement. References within the text should be given in the form of (Jones 
& Smith, 1973). When there are three or more authors the first citation should be given 
as Williams et al. (1973). The appropriate positions of tables and figures should be 
indicated in the text. Footnotes should be avoided where possible.  
 
• References should be in the APA style. All citations in the text should be listed in 
strict alphabetical order according to surnames. Multiple references to the same author 
should be listed using a, b, etc., for entries within the same year.  
Note: Authors are encourages to include digital object identifiers (dois) in their citation 
listings, as follows: Kaltenthaler, E., Parry, G. and Beverley, C. (2004). Computerised 
cognitive behaviour therapy: a systematic review. Behavioural and Cognitive 
Psychotherapy, 32, 31–55. doi:10.1017/S135246580400102X.  
 
• Declaration of interests should be included with all papers, if there are none this 
should be stated.  
 
• Acknowledgements. May include previous unpublished presentations (e.g. 
















APPENDIX J- Main Research Journal Instructions for Authors 
Psychology and Psychotherapy: Theory, Research and Practice 
Author Guidelines 
All papers published in Psychology and Psychotherapy: Theory, Research and Practice are 
eligible for Panel A: Psychology, Psychiatry and Neuroscience in the Research Excellence 
Framework (REF). 
Length  
All articles submitted to PAPT must adhere to the stated word limit for the particular article 
type. The journal operates a policy of returning any papers that are over this word limit to the 
authors. The word limit does not include the abstract, reference list, figures and tables. 
Appendices however are included in the word limit. The Editors retain discretion to publish 
papers beyond this length in cases where the clear and concise expression of the scientific 
content requires greater length (e.g., a new theory or a new method). The authors should 
contact the Editors first in such a case.  
Word limits for specific article types are as follows:  
• Research articles: 5000 words 
• Qualitative papers: 6000 words 
• Review papers: 6000 words 
• Special Issue papers: 5000 words 
Manuscript requirements  
• Contributions must be typed in double spacing with wide margins. All sheets must be 
numbered.  
• Manuscripts should be preceded by a title page which includes a full list of authors and their 
affiliations, as well as the corresponding author's contact details. A template can be 
downloaded here.  
• The main document must be anonymous. Please do not mention the authors’ names or 
affiliations (including in the Method section) and refer to any previous work in the third 
person.  
• Tables should be typed in double spacing, each on a separate page with a self-explanatory 
title. Tables should be comprehensible without reference to the text. They should be placed at 
the end of the manuscript but they must be mentioned in the text.  
• For articles containing original scientific research, a structured abstract of up to 250 words 
should be included with the headings: Objectives, Design, Methods, Results, Conclusions. 
Review articles should use these headings: Purpose, Methods, Results, Conclusions.  
• All Articles must include Practitioner Points – these are 2-4 bullet points, in addition to the 
abstract, with the heading ‘Practitioner Points’. These should briefly and clearly outline the 
relevance of your research to professional practice.  
• For reference citations, please use APA style. Particular care should be taken to ensure that 
references are accurate and complete. Give all journal titles in full and provide DOI numbers 
where possible for journal articles.  
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• SI units must be used for all measurements, rounded off to practical values if appropriate, 
with the imperial equivalent in parentheses.  
• In normal circumstances, effect size should be incorporated.  
• Authors are requested to avoid the use of sexist language.  
• Authors are responsible for acquiring written permission to publish lengthy quotations, 
illustrations, etc. for which they do not own copyright.  
• Manuscripts describing clinical trials must be submitted in accordance with the CONSORT 
statement on reporting randomised controlled trials (http://www.consort-statement.org).  
For guidelines on editorial style, please consult the APA Publication Manual published by the 
American Psychological Association.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
